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CHAPTER 1 
Introduction
Billions o f dollars are spent in the United States each year for the treatment of 
diabetes. Over half that cost is spent on patient hospitalizations caused from the 
complications associated with diabetes. (Ratner, 1996) Results of randomized clinical 
trials by the Diabetes Control and Complications Trial demonstrated that in patients with 
type 1 diabetes the risk of development or progression of long-term complications is 
reduced 50-75% by intensive treatment programs. The reduction in risk of 
complications from diabetes correlates with the patient’s achievement of near normal or 
normal blood glucose levels. (American Diabetes Association; Clinical Practice 
Recommendations, 1995; American Diabetes Association: Clinical Practice 
Recommendations, 1997) For the past several years the American Diabetes Association 
(ADA) has been actively involved in developing diabetes care standards and guidelines 
to aid in the establishment of intensive treatment programs. These standards and 
guidelines are issued annually and are known as the American Diabetes Association; 
Clinical Practice Recommendations. Specific guidelines for the treatment of patients 
with diabetes are referred to as the ADA’s “Standards of Medical Care for Patients With 
Diabetes Mellitus.” The treatment goal of the standards of medical care is to prevent 
acute complications and to reduce the risk of long-term complications by lowering blood 
glucose levels to or near normal (American Diabetes Association: Clinical Practice 
Recommendations, 1995; American Diabetes Association: Clinical Practice 
Recommendations, 1997) This treatment goal can only be achieved if  physicians provide
intensive treatment programs for their patients. The standards of medical care offer 
clinics and hospitals a unique opportunity to review the quality of care their physicians 
are providing for patients with diabetes.
Objectives of Professional Paper 
The objectives of this professional paper are, 1) to provide a model of an 
assessment process to judge physician compliance to the ADA’s “Standards of Medical 
Care for Patients with Diabetes Mellitus”, 2) to provide assessment results using a 
participating clinic in Montana as a model, 3) to design a one-page retrospective 
assessment tool to gather the information needed to assess physician compliance to the 
ADA Standards who treat patients with type 1 diabetes, and 4) to offer recommendations 
which will include the design of a one-page flow-sheet that can be placed in all medical 
charts of patients with type 1 diabetes to prompt physician adherence.
Assumptions
For the purpose of this study the following assumptions were made;
1. The quality of a physician’s medical care includes many aspects, for the purpose 
of this study quality of care was specifically related to physician compliance to 
the ADA Standards of Care.
2. The ADA Standards allow for differing interpretations, however, for the purpose 
of this study the strictest interpretation of the ADA Standards was assumed to 
insure optimal care for all patients with type 1 diabetes.
3. Patients are defined as having type 1 diabetes if  they were diagnosed with 
diabetes before the age of 40 years and/or they started insulin therapy within the 
first year of diagnosis. (American Diabetes Association; Clinical Practice 
Recommendations, 1995; American Diabetes Association: Clinical Practice 
Recommendations, 1997)
4. Physicians received visitation credit if  the patient was seen for a diabetic or non­
diabetic visit. Type 1 diabetes affects all aspects of medical care received by the 
patient and should always be discussed by the physician regardless o f the type of 
visit.
5. If a patient vsith type 1 diabetes had an appointment with a dietitian, nurse 
educator, or ophthalmologist the patient’s diabetes physician received referral 
credit.
Delimitations
1. The subjects of this study were the physicians employed at the participating clinic 
treating patients with type 1 diabetes.
2. The participating clinic consists of a main clinic and two satellite clinics. The 
main clinic provides services for a community of approximately 100,000 people. 
The satellite clinics provide services for rural communities
3. This project was limited to review of physician compliance regarding the ADA’s 
Standards. Patient charts were reviewed to assess physician compliance, patient 
compliance was not a focus of this project.
4. Medical charts of patients with type 1 diabetes were reviewed for the years of 
1995 and 1996. These years were chosen because they provide current 
information on care by physicians still employed at the clinic and the ADA’s 
yearly update to their Clinical Practice Recommendations did not include any 
changes to the “Standards o f Medical Care for Patients With Diabetes Mellitus”.
5. Medical charts of patients with type 1 diabetes receiving hemodialysis or 
peritoneal dialysis were excluded from the study based on the patient’s need for 
varying treatment.
6. Data from medical charts of patients with type 1 diabetes were excluded from 
the study if during the last documented visit their physician stated that the patient 
needed to return for a check-up during a specified time period and the patient 
never returned. The years of 1995 and 1996 were judged separately according to 
this criteria.
7. Data collected from 1995 were excluded from the study if the patient established 
care with the physician or was diagnosed with type 1 diabetes during that year, 
however, the data collected from 1996 were included. Likewise, data collected 
from 1996 were excluded if the patient established care with the physician or was 
diagnosed with type 1 diabetes during that year.
8. Data from patients with type 1 diabetes were excluded from the study if they were 
receiving care from another physician not employed at the participating clinic and 
were seen by a physician at the participating clinic on a referral basis.
9. Data from patients with type 1 diabetes were excluded from the study if the 
physician stated in the patient’s file that the patient was non-compliant to 
treatment and was deliberately avoiding care.
10. Physicians treating children with type 1 diabetes were not held accountable for 
the lipid profile standard due to the ADA stipulation “if  values fall within 
accepted risk levels, assessment should be repeated every five years.” (American 
Diabetes Association: Clinical Practice Recommendations, 1995)
11. This study focuses on only one participating clinic. No attempt will be made to 
generalize any of this study’s findings to other clinics or hospitals.
Significance of Professional Paper 
The ADA’s recommendations for the treatment of patients with diabetes are 
considered the gold standard in the health care community, however, the question needs 
to be asked “Are those standards of medical care being followed by physicians and other 
health care providers?” The ADA suggests that if intensive treatment regimens were 
followed, a decrease in the amount of money spent on the treatment of diabetes would be 
seen due to the decrease in the incidence of long-term complications. However, the cost 
of treating patients with diabetes for long-term complications continues to rise at a rate 
disproportionate to other health care costs. In fact, 4.5% of the population, those with 
diabetes, accounted for 14.6% of the total health care expenditure in the United States in 
1992, or $105 billion; 66% of that cost was spent on hospitalizations due to long-term
complications. (Ratner, 1996) A review of the literature has shown only one 
documented study assessing compliance to the ADA Standards, however, this study was 
performed on rural physicians in Ohio caring for patients with type 2 diabetes. (Zoorob 
& Mainous, 1996) This suggests that health care providers may be unaware of the 
quality of care physicians are providing to their patients with diabetes. Quality of 
physician care for patients with diabetes is unlikely to improve if clinics and hospitals 
continue this approach.
This professional paper has clinical significance. This project should serve other 
participating clinics in several ways by, firsts providing a model o f an assessment process 
to judge physician compliance to the ADA’s “Standards of Medical Care for Patients 
with Diabetes Mellitus”. Second, assessment results will be provided using a clinic in 
Montana as a model to demonstrate the assessment process. Third, this project will 
provide the design of a one-page retrospective assessment tool which follows the ADA 
Standards to collect information from patient’s medical charts who have type I diabetes. 
Fourth, this project will provide the design of a one-page flow-sheet that can be placed in 
all medical charts of patients with type 1 diabetes enabling physicians to track the ADA 
Standards to help prompt adherence
CHAPTER 2 
Review of Related Literature 
Types and Prevalence of Diabetes 
Diabetes Mellitus is characterized by persistent hyperglycemia due to insulin 
deficiency or to resistance of the body’s cells to the action of insulin. Four major types 
of diabetes have been defined by the National Diabetes Data Group and the World Health 
Organization: insulin-dependent diabetes mellitus (IDDM) or type 1 diabetes, non­
insulin-dependent diabetes mellitus (NÏDDM) or type 2 diabetes, gestational diabetes 
mellitus (GDM), and diabetes secondary to other conditions. (Harris, 1995)
In 1993 the National Health Interview Survey reported approximately 7.8 million 
diagnosed cases of diabetes in the United States. Patients with type 1 diabetes with onset 
at age less than 30 years comprise approximately 7% of all diagnosed cases. The 
remainder of diagnosed cases are considered to be patients with type 2 diabetes.
Estimates suggest that there are approximately seven to eight million undiagnosed cases 
of type 2 diabetes in the United States. Diabetes secondary to other conditions occurs in 
1-2% of all diabetes patients. GDM occurs in 3-5% of all pregnancies. Patients with 
diabetes comprise approximately 4.5% of the population in the United States, (Harris,
1995) For the purpose of this professional paper, this project is limited to the review of 
patient care in patients with type 1 diabetes
In the United States it is estimated that 120,000 children (less than age 20 years) 
and approximately 300,000-500,000 individuals of all ages have type 1 diabetes. There 
may also be another 500,000 individuals with adult-onset type 1 diabetes who were
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diagnosed after the age of 30 years. Incidence of type 1 diabetes is 30,000 new cases 
each year in the United States. More than half of these cases occur in children, making 
type 1 diabetes one of the most frequent chronic disease in United States children.
(Harris, 1995)
More than 80% of type 1 diabetes cases occur in children with no family history 
of the disease. Occurrence of type 1 diabetes among identical twins is only 30-50%, 
much less than would be expected for a disease with strictly a genetic basis. However, in 
families with a person who has type 1 diabetes, a relative’s risk of type 1 diabetes is 
much greater. Prevalence of type 1 diabetes by age 30 in siblings or children of patients 
with type 1 diabetes is 2-6% compared to only less than 0.2% in the general population. 
(Harris, 1995)
Epidemiological Patterns of Type 1 Diabetes
Average Age of Onset
A Diabetes Epidemiological Research Group in Pittsburgh, PA researched the 
incidence of type 1 diabetes by the age of onset. They reported that there are few cases 
of type I diabetes developing within the first year of life. Evidence suggests that the age- 
of-onset of type 1 diabetes characteristically falls during the pubertal peak. (Gavard, 
1996) Onset of type 1 diabetes is most frequent at age 10-14 years. Males are slightly 
older in age at onset than females. (Cowie & Harris, 1995; LaPorte, Matsushima, & 
Chang, 1995)
Age and Sex Distribution
The age distribution among adult patients with type 1 diabetes is very different 
from the total adult population. The median age among patients with type 1 diabetes age 
older than 18 is 32 years, as opposed to 40 years for persons without diabetes. A study 
done in Allegheny County, PA between the years of 1965-89 showed an age range of 0- 
44 years among persons with type 1 diabetes who were diagnosed before the age of 20 
years; most of these patients were between the ages of 25-29. In the United States 
studies indicate that there are slightly more white males (53.4%) older than 18 with type 
1 diabetes than white females (46.6%) older than 18. (Cowie & Harris, 1995)
Racial^Differences
Ethnic and racial differences are clear in the incidence of type 1 diabetes. The 
highest incidence is among white children with 13.3-20.6 per 100,000 new cases each 
year. Puerto Rican children average 15.2 new cases per 100,000 each year. These two 
groups are followed by Mexican-American children (4.1-9.7/100,000) and black children 
(3.3-11.0/100,000). (Gavard, 1996)
Seasonal Patterns
Onset of type I diabetes occurs in seasonal patterns. Research has shown a 
decline in the number of new cases in the summer months and a higher incidence during 
the winter months. (LaPorte et al., 1995) Studies on the seasonality of onset of type 1 
diabetes have discovered that the onset of the disease parallels that of common
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infections, such as congenital rubella syndrome and the mumps virus. Studies indicate 
that these infections may be related to type 1 diabetes. These common infections peak 
during late autumn and winter with few cases occurring in the summer months. (Gavard,
1996) This pattern is seen consistently across the nation. (LaPorte et al., 1995)
Duration o f Type 1 Diabetes
Studies performed in Allegheny County, PA showed that duration (the length of 
time a person has been diagnosed with type 1 diabetes) of type 1 diabetes is evenly 
distributed between 0-24 years. Most patients with type 1 diabetes (60%) have durations 
lasting at 15 years or more (Cowie & Harris, 1995)
Life Expectancy
The life expectancy of patients with type 1 diabetes is reduced by approximately 
15 years. The majority of deaths of individuals with type 1 diabetes occurs in middle and 
late adulthood, with greater than 15% of patients with type 1 diabetes dying by the age of 
40 Mortality rates in male patients with type 1 diabetes are five to seven times and in 
females 9 to 12 times that of the general United States population. The leading cause o f 
death for persons with type 1 diabetes changes with the duration of the disease. Acute 
coma is the leading cause of death in the early years after diagnosis. Renal disease is the 
leading cause of death in the middle years. Two-thirds of deaths result from 
cardiovascular disease in patients who have had type 1 diabetes for more than 30 years. 
(Harris, 1995)
I l
Possible Causes of  Type 1 Diabetes 
Type 1 diabetes is characterized by the absence of insulin activity. Patients with 
type 1 diabetes may be of any age, are not usually obese, and often have abrupt onset of 
signs and symptoms before the age of 30. Hyperglycemia, and often times ketones 
present in the urine, are signs of type 1 diabetes in the newly diagnosed patient.
Symptoms of type 1 diabetes includes polydipsia, polyphagia, and polyuria. Insulin 
therapy is needed to sustain life. (Ratner, 1996)
The cause of type 1 diabetes is still not clearly understood. Genetic and 
environmental risk factors have been researched and both appear to contribute to the 
disease. Environmental risk factors include infectious agents, stress, lack of breast­
feeding, and ingestion of cow’s milk proteins. (Gavard, 1996)
The research states that for some reason the body produces antibodies against its 
own insulin producing beta islet cells effectively destroying them. Researchers suggest 
this may occur because a foreign substance, a bacterium or virus, invades the body. This 
foreign substance is believed to be similar to the insulin producing beta cells of the 
pancreas. The body may recognize this substance as a bacterium or virus and develop 
antibodies against the foreign substance, destroying it along with the beta cells. (Dorman, 
McCarthy, O’Leary, & Koehler, 1995; Gavard, 1996)
Genetic Risk Factors
Genetic research has found that persons are susceptible to type 1 diabetes if they 
contain unique gene markers located on chromosome 6. Persons with type 1 diabetes are
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significantly more likely to have these unique gene markers than persons without 
diabetes. However, these gene markers are common in the general population and a 
great majority of the individuals with these unique gene markers do not develop type 1 
diabetes. This evidence suggests individuals may inherit a susceptibility to the disease. 
Genetic susceptibility to type I diabetes may make certain individuals more likely to 
develop the disease if  they come into contact with an environmental risk factor.
(Dorman et al., 1995; Gavard, 1996)
EnvironmeiitaLRisk Factors
Environmental risk factors may initiate beta cell destruction resulting in either a 
slow, progressive beta cell destruction that may take years to result in the disease or rapid 
destruction of beta cells quickly initiating the diabetes condition. Epidemiological 
patterns of most infectious diseases, particularly viral illnesses, are similar to those of 
type I diabetes. These similarities include age of onset in mainly younger age groups 
and a more frequent occurrence of the disease during the winter months. Viruses 
associated with the development of type I diabetes are the Coxsackie B virus, congenital 
rubella syndrome, and the mumps virus. These viruses may initiate type I diabetes 
through the rapid destruction of beta cells or they may merely damage beta cells 
developing into type I diabetes with the action of additional environmental stressors. 
(Dorman et al., 1995; Gavard, 1996)
Stress has been implicated as a causal agent in persons with type I diabetes. 
Studies indicate a greater proportion of adolescents with diabetes suffered a parental loss
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before onset compared to adolescents without diabetes. Parental loss was defined as 
divorces, separations, or deaths. Other studies indicate a greater number of adolescents 
with type 1 diabetes suffered a severe life event three years prior to onset. Severe life 
events included highway accidents and breaking off a significant relationship. These 
findings suggest stress may be an initiating factor for type 1 diabetes in a genetically 
susceptible individual. (Dorman et al., 1995; Gavard, 1996)
Various nutritional practices have been associated with the development o f type I 
diabetes. The immunologic properties of breast-feeding may provide a protective effect 
against the development of type I diabetes. Studies indicate a smaller proportion of 
children with type I diabetes had been breast-fed and for shorter periods of time than 
their siblings without type 1 diabetes. However, the protection against type 1 diabetes 
may not come directly from breast milk but from the delay of other milk products such as 
cow’s milk. An increased risk of type I diabetes has been associated with the 
introduction of breast milk substitutes before the age of three months. Cows’ milk is the 
most widely studied breast milk substitute. The infants body, through an autoimmune 
response, attacks its own insulin producing beta cells. An infant’s gut is in an immature 
state approximately three months after birth. A cow’s milk protein, bovine serum 
albumin, may pass directly into the infant’s bloodstream causing the infant’s immune 
system to become sensitized. The beta cells and the cow’s milk protein are so similar the 
infant’s immune system is unable to distinguish between them. The infant’s 
immunologic reaction to the cow’s milk protein destroys it and the insulin producing 
beta cells. This theory has been supported by elevated bovin serum albumin antibodies
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in recently diagnosed children with type 1 diabetes. (Dorman et al., 1995; Gavard, 1996) 
Studies in Canada, the United States, Sweden, Finland, and other countries have 
found a positive correlation between the incidence of type 1 diabetes and the intake of 
cow’s milk and a negative correlation between type 1 diabetes and breast-feeding 
through at least the age of three months A study in Allegheny County, PA on Caucasian 
children with type 1 diabetes revealed that these children were 50% less likely to have 
been breast-fed than those without type 1 diabetes. A study in Colorado on the early 
exposure to cow’s milk and type 1 diabetes discovered that individuals with type 1 
diabetes were 11 times more likely to have been exposed to cow’s milk before the age of 
three months. Many studies on breast-feeding or early exposure to cow’s milk and the 
development of type 1 diabetes revealed that patients with type 1 diabetes were 43% 
more likely to have been breast-fed less than three months and 63% more likely to have 
been exposed to cow’s milk before the age of three to four months These studies further 
conclude that the early exposure to cow’s milk may be an important risk factor for the 
development of type 1 diabetes and appears to increase the risk by 50%. (Dorman et al., 
1995; Gavard, 1996)
Complications of Tvpe 1 Diabetes 
Approximately $105 billion is spent each year caring for patients with diabetes,
14 6% of the total health care cost in the United States. More than 600,000 emergency 
room visits are required annually by persons with diabetes, and when hospitalized, 
persons with diabetes stay almost three days longer compared to individuals with
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diabetes. Hospitalizations account for 66% of the total health care costs for persons with 
diabetes. This suggests an enormous health care savings if  the complications caused by 
diabetes can be prevented. (Ratner, 1996)
Acute Complications of Type 1 Diabetes
Diabetic Ketoacidosis
Complications from type 1 diabetes can be either acute or long-term. The most 
severe acute complication of type 1 diabetes is diabetic ketoacidosis (DKA). DKA is 
primarily a state of absolute insulin deficiency. Because insulin is not available, glucose 
cannot be used as a cellular fuel. The body then relies on the increased use of fat 
metabolism. As fat breakdown is increased, ketone bodies accumulate in the blood. 
When ketones, organic acids, accumulate faster than they can be used or excreted, 
ketosis results and blood pH drops, resulting in ketoacidosis (pH less than 7.3). If 
untreated, ketosis can lead to a coma, and eventually, death. DKA is identified in 
approximately 40% of patients with newly diagnosed type 1 diabetes and is responsible 
for more than 160,000 hospitalizations each year. The development of DKA in a person 
with known diabetes is often considered treatment failure. Studies have shown reasons 
for the occurrence of DKA which include lack of diabetes education and training, patient 
non-compliance, poor self-care, inadequate glucose monitoring, and psychological 
problems. (Fishbein & Palumbo, 1995) The most common cited cause to DKA is an 
acute illness or infection A decrease in death from acute complications, such as DKA, 
has been attributed to the availability of insulin since 1922. (White & Henry, 1996)
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Studies have shown a reduction in DKA hospitalizations Wien the patient was 
accompanied by patient education, follow-up care, and an increased access to medical 
advice. (Fishbein & Palumbo, 1995)
Hypoglycemia
Hypoglycemia, or an insulin reaction, occurs from an excess of insulin in the 
blood resulting in excessively low blood glucose levels. Each person is unique in the 
level of glucose that produces symptoms of hypoglycemia. (American Diabetes 
Association: Clinical Practice Recommendations, 1997) Hypoglycemia may range from 
mild (60-70 mg/dl) with minimal or no symptoms, to severe (less than 40 mg/dl). 
(Fishbein & Palumbo, 1995) Hypoglycemia usually occurs and is typically accompanied 
by warning signs which may include perspiration, rapid heartbeat, shakiness, anxiety, and 
hunger Prevention of hypoglycemia occurs with the ingestion of carbohydrates A 
hypoglycemic reaction can result in a loss of consciousness or a seizure if the individual 
does not present warning signs or ignores warning signs. More severe hypoglycemia 
reactions can occur if blood glucose levels continue to fall including confusion, stupor, 
and finally unconsciousness. (American Diabetes Association: Clinical Practice 
Recommendations, 1997)
Long-term Complications of Tvpe 1 Diabetes
The majority of health care costs today are associated with the treatment of the 
chronic complications associated with diabetes. (Ratner, 1996) The Diabetes Control
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and Complications Trial has demonstrated that near normal blood glucose levels can 
prevent or slow the progression of these diabetic complications. ( American Diabetes 
Association: Clinical Practice Recommendations, 1995)
Microvascular Complications
The microvascular complications associated with diabetes are nephropathy, 
retinopathy, and neuropathy. For many decades, the cause of these complications 
remained unclear. Early cross-sectional and observational studies indicated an 
association between hyperglycemia and microvascular complications. However, a causal 
relationship was never determined. In the 1980s the methods to improve glycémie 
control, self-monitoring and intensive insulin treatments, and the methods to assess the 
impact of therapy, glycohemoglobin, became available and allowed for the initiation of 
prospective clinical trials. The Diabetes Control and Complications Trial (DCCT) 
recruited 1441 patients from 29 centers between 1983 and 1989. These subjects were 
followed for an average of 7 years. The trial was terminated in 1993. These randomized 
clinical trials were designed to compare the impact of intensive and conventional therapy 
on the development and progression of microvascular complications. The results of the 
DCCT conclusively proved that hyperglycemia causes microvascular and neuropathic 
complications in patients with type 1 diabetes. The DCCT also proved that in patients 
with type 1 diabetes intensive therapy both delays the onset and slows the progression of 
retinopathy, nephropathy, and neuropathy. (American Diabetes Association: Clinical 
Practice Recommendations, 1997)
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Diabetic Nephropathy 
Diabetes has become the fastest growing cause of end-stage renal disease (ESRD) 
in the United States. The number of new cases o f diabetic ESRD has increased from 
2200 people in 1980 to 13,300 people in 1989. These growing numbers are attributed to 
the increase in prevalence of diabetes and because patients with diabetes are living much 
longer today than in previous decades. Diabetic nephropathy accounts for about one- 
third of all cases of ESRD. Dialysis or kidney transplant are the only two options for 
survival. (Herman & Greene, 1996)
The first clinical evidence of nephropathy is the appearance of low levels of 
albumin in the urine, referred to as microalbuminuria. Patients with clinical signs of 
microalbuminuria are referred to as having incipient nephropathy. This stage usually 
occurs 10 to 15 years after diagnosis of type 1 diabetes. Urinary albumin increases at a 
rate of 10-20 % per year to the stage of overt nephropathy. Overt nephropathy develops 
15 to 25 years after onset of diabetes in about 40% of people with type 1 diabetes. Overt 
nephropathy occurs in 80% of subjects with type 1 diabetes who have already developed 
incipient nephropathy. Fifty percent of patients with overt nephropathy progress to 
ESRD within 5 to 10 years, and greater than 75% by 20 years. ESRD is the leading cause 
of death in type 1 diabetes during middle age. (Herman & Greene, 1996)
Patients with type 1 diabetes usually develop hypertension at the same time as the 
development of microalbuminuria caused by diabetic nephropathy. Systolic and diastolic 
hypertension accelerate the progression of diabetic nephropathy. However,
19
antihypertensive intervention such as weight loss, reduction of salt and alcohol intake, 
exercise, and the use of angiotensin-converting enzyme (ACE) inhibitors greatly reduce 
mortality from 94% to 45% and a reduction in the need of dialysis and transplantation 
from 73% to 31% 16 years after the development of overt nephropathy. (American 
Diabetes Association: Clinical Practice Recommendations, 1997)
Diabetic Retinopathy 
Diabetic eye disease is the leading cause of new cases o f blindness in American 
adults aged 20-74. Blindness cause from diabetes is estimated to involve lost income and 
public welfare expense of $500 million annually. (Klein & Klein, 1995) The prevalence 
of retinopathy is strongly related to the duration of diabetes. Vision threatening 
retinopathy does not usually occur in patients with type 1 diabetes in the first five years 
of diabetes or before puberty. However, within the next 20 years nearly all patients with 
type 1 diabetes develop retinopathy. (Herman & Greene, 1996) Diabetic retinopathy is 
characterized by specific alterations in the appearance of the retina. (Klein & Klein, 
1995)
Diabetic retinopathy advances in progressive stages. Nonproliferative diabetic 
retinopathy is the earliest stage and most often is first seen as a retinal microaneurysm, a 
small out-pouching of a retinal capillary that appears as a small red dot on the retina. 
Preproliferative diabetic retinopathy, the second stage, is characterized by closure of 
retinal capillaries and arterioles. These changes cause the nerve fibers of the retina to 
swell. Proliferative diabetic retinopathy, the most advanced stage, is characterized by the
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growth of new blood vessels onto the retina. Blindness can occur if these new blood 
vessels contract resulting in a distorted retina or retinal detachment. This is often 
irreversible. New blood vessels also have a tendency to bleed, adding further 
complications. (Herman & Greene, 1996)
Diabetic Neuropathy 
Diabetes is the most common cause of neuropathy in the United States. Diabetic 
neuropathy can be defined as peripheral nerve dysfunction that occurs in persons with 
established diabetes. Diabetic neuropathy causes suffering, disability, and lower 
extremity amputations. (Herman & Greene, 1996)
Diabetic neuropathy is classified into two groups, these groups are further 
classified into several types of neuropathies. Each type of neuropathy has specific 
characteristics, symptoms, and signs. Each syndrome is distinct, however much of the 
time syndromes appear together making classification difficult. The two main types of 
diabetic neuropathy are diffuse and focal. The most common type of diffuse neuropathy 
is distal symmetric sensorimotor polyneuropathy. It is a sensory neuropathy mostly 
involving the toes and feet. Distal symmetric sensorimotor polyneuropathy can cause 
acute pain, diminished pain and temperature sensation, or loss of light touch, vibration, 
and sensation depending on the nerve fibers involved. Another form of diffuse 
neuropathy is diabetic autonomic neuropathy. Manifestations of diabetic autonomic 
neuropathy include abnormal sweating, abnormal pupillary function, cardiovascular 
neuropathy, gastrointestinal neuropathy, constipation, diarrhea, genitourinary neuropathy
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affecting bladder and sexual functions, and hypoglycemic unawareness. Focal 
neuropathy is associated with problems in a single nerve, multiple nerves, the brachial or 
lumbosacral plexus, or the nerve roots. Studies indicate that 66% of patients with type 1 
diabetes have some form of neuropathy. (Herman & Greene, 1996)
Macrovascular Disease
Macrovascular disease is defined as disorders of large vessels with resultant 
morbidity and mortality. Macrovascular disease manifests as heart disease (myocardial 
infarction), central nervous system conditions, cerebrovascular accident (CVA, stroke), 
and lower extremity disease (vascular foot ulcers). (Vinicor, 1996)
Various factors contribute to accelerated and premature macrovascular disease.
In the person with diabetes, hyperglycemia has proven to be a factor. Hyperglycemia 
may place the internal lining of large vessels at risk. Hyperglycemia coupled with 
hyperlipidemia contributes to atherosclerosis. Metabolic consequences of hyperglycemia 
include neuropathy which can lead to abnormal cell wall nutrition and 
sympathetic/parasympathetic denervation. The clotting systems of persons with diabetes 
have proven to be abnormal including platelet function, blood flow, and blood viscosity. 
For example, platelets appear sticky and blood flow is sluggish. These abnormalities 
could increase the likelihood of macrovascular disease. (Vinicor, 1996)
Hypertension is common among persons with diabetes. Family history, a genetic 
predisposition, and being male are all risk factors that may predispose a person with 
diabetes to develop hypertension. The administration of insulin therapy may also be a
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risk factor. Increased insulin concentrations stimulate sodium reabsorption resulting in 
fluid retention. Continued investigations are looking into the speculation that insulin 
may contribute to macrovascular disease. (Vinicor, 1996)
Lower Extremity Problems
Persons with diabetes are at a high risk for lower extremity amputations. In the 
United States, persons with diabetes constitute 50% of the 100,000 lower extremity 
amputations performed each year. Poorly controlled diabetes results in lower extremity 
neuropathy and arteriosclerosis causing lower extremity problems. (Coleman, 1996)
Neuropathy often times results in the loss o f touch and pain sensation, the 
protective senses. Nerve impairment caused from neuropathy and a continuous trauma 
can lead to ulceration development and infection. Trauma can be caused from high 
pressure penetrating wounds, such as stepping on a piece of glass or a tack, low pressure 
pain caused from poorly fitting shoes, or moderate rep>etitive pressure often times caused 
from the repetitive stress from walking. The person with diabetes who is insensitive to 
touch and pain would not feel any of these traumas. Arteriosclerosis compromises 
circulation in lower extremities caused from partial blockages. These blockages can 
amplify the trauma because the wound is unable to heal properly. Physicians identifying 
the development of neuropathy and arteriosclerosis in the lower extremities, educating 
patients to better care for their diabetes, and teaching patients to properly care for their 
feet can help prevent lower extremity amputations. (Coleman, 1996)
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Diabetes Control and Complications Trial (DCCT) and The ADA's Standards 
Diabetes Control and Complications Trial (DCCT)
The Diabetes Control and Complications Trial (DCCT) was the longest and 
largest prospective study on type 1 diabetes designed to test the theory that the 
complications associated with diabetes mellitus are related to elevated blood glucose 
levels. The DCCT was a landmark multicenter trial that followed two groups of patients 
with type 1 diabetes for an average of 7 years, one group was treated conventionally 
(goal: clinical well-being, called the standard treatment group) and the other group was 
treated intensively (goal: normalization of blood glucose, called the intensive treatment 
group). The intensive treatment group was clearly distinguished from the standard 
treatment group in terms of hemoglobin A 1C values. A glycated hemoglobin test, or 
hemoglobin A 1C, is a clinical laboratory test that is able to measure the average blood 
glucose level of a patient over a two to three month period Glycated hemoglobin is a 
term used to describe a hemoglobin component formed from hemoglobin (oxygen 
transporting component of erythrocytes) and glucose. The rate of formation of glycated 
hemoglobin is directly proportional to the ambient glucose concentration in the blood 
stream. Since erythrocytes (red blood cells) are permeable to glucose, the level of 
glycated hemoglobin in a blood sample provides a glycémie history of the previous 120 
days, the average erythrocyte life span. A normal hemoglobin A lC for a person without 
diabetes is 4.0-6 0% (70-110 mg/dl). The intensive treatment group’s glycated 
hemoglobin levels averaged 7.2% (155 mg/dl). The standard treatment group’s glycated
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hemoglobin levels averaged 9.0%. The DCCT results showed a 60% reduction in risk 
between the intensive treatment group and the standard treatment group in diabetic 
retinopathy, nephropathy, and neuropathy. The benefit of intensive therapy resulted in 
the delay in the onset and a major slowing in the progression of these complications. The 
DCCT demonstrated that there was also no increase in cardiovascular disease in the 
intensive treatment group. These results were seen in all categories of the intensive 
treatment group regardless o f age, sex, or duration of diabetes. (American Diabetes 
Association: Clinical Practice Recommendations, 1997)
Goals and Benefits of the Standards of Care
The American Diabetes Association (ADA) believes that the DCCT is both 
statistically and clinically significant and believes that the primary treatment goal in type 
1 diabetes should be blood glucose control at least equal to that achieved in the DCCT 
intensive treatment group. The ADA has been actively involved in developing standards 
for care of diabetes mellitus patients for several years. The ADA’s goal is to design an 
intensive treatment program for all patients with diabetes in hopes of paralleling the 
results of the DCCT. Throughout each year the journal “Diabetes Care” and a few other 
professional journals publish the ADA’s Clinical Practice Recommendations which 
includes current recommendations for the treatment of patients with diabetes. The ADA 
strives to serve as a convenient resource for all health-care professionals who care for 
people with diabetes. Within the health care community the ADA recommendations are 
considered the gold standard on how to optimally treat patients with diabetes mellitus.
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The ADA calls these recommendations the “Standards of Medical Care for Patients With 
Diabetes Mellitus”.
The ADA believes that all patients with diabetes should receive treatment and 
care from a physician-coordinated team This team should include a physician, dietitian, 
nurse, and mental health care professionals with expertise in the management of 
diabetes The standards of diabetes care seek to provide physicians and other health care 
professionals who treat people with diabetes with a means to set treatment goals, assess 
the quality of diabetes treatment provided, identify areas where more attention or self­
management training is needed, and define timely and necessary referral patterns to 
appropriate specialists. These standards also seek to provide patients with diabetes with 
a means to assess the quality of medical care they receive, develop expectations for their 
role in the medical treatment, and compare their treatment outcomes to standard goals. 
(American Diabetes Association: Clinical Practice Recommendations, 1995; American 
Diabetes Association: Clinical Practice Recommendations, 1997)
The ADA believes that treatment should be aimed at lowering blood glucose 
levels to or near normal in all patients. The proven benefits (American Diabetes 
Association: Clinical Practice Recommendations, 1995; American Diabetes Association; 
Clinical Practice Recommendations, 1997) of lowering blood glucose levels are as 
follows:
1. The danger of diabetic ketoacidosis with its accompanying morbidity and 
mortality is markedly reduced, (p. 8)
2. The symptoms of blurred vision are alleviated and the risk of polyuria.
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polydipsia, fatigue, weight loss with polyphagia, and vaginitis may be 
decreased, (p. 8)
3. The risks o f development o f progression of diabetic retinopathy, 
nephropathy, and neuropathy are all greatly decreased. These 
complications may even be prevented by early normalization of 
metabolic status, (p. 8)
4. Near normalization of blood glucose has been demonstrated to be 
associated with less atherogenic lipid profile, (p. 8)
The DCCT has demonstrated that patients with type 1 diabetes reduce their risk 
of development or progression of retinopathy, nephropathy, and neuropathy by 50-75% 
with intensive treatment regimens when compared to standard treatments. The desired 
outcome of glycémie control for the patient with type 1 diabetes is to lower hemoglobin 
AlC values to achieve maximum prevention from complications. Frequent blood 
glucose monitoring (at least three to four times per day), nutritional counseling, training 
in self-management and problem solving, and possible hospitalization for initiation of 
therapy are all necessary to achieve desired hemoglobin AlC values with intensive 
treatment programs. (American Diabetes Association: Clinical Practice 
Recommendations, 1995; American Diabetes Association; Clinical Practice 
Recommendations, 1997)
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Guidelines for Ihe Initial Visit
To help aid health care professionals the ADA offers “initial visit” and 
“continuing care” guidelines. During the initial visit the physician should obtain a 
comprehensive medical history from the patient, a complete a physical exam, and 
laboratory evaluations. The goal of the initial visit is to review previous treatment, 
evaluate past and present glycémie control, and determine the presence or absence of 
chronic complications. (American Diabetes Association; Clinical Practice 
Recommendations, 1995) This information should provide a basis for continuing care.
Guidelines for Continuing Care
Guidelines for continuing care include visitation frequency, changes in medical 
history, a physical examination, laboratory evaluations, and a reassessment of the 
management plan. The visitation frequency guideline is defined as regular visits 
scheduled for insulin-treated patients at least quarterly. The physical exam guidelines 
are height (until maturity), weight, and blood pressure determinations during every 
regular visit. The feet should be examined at every regular visit to assess skin condition, 
sensation, and vascular status. Included in the physical examination guideline is a 
referral from the diabetes physician for a comprehensive dilated eye and visual 
examination. The dilated eye and visual exam should be performed annually by an 
ophthalmologist or optometrist for all patients age 12 and over who have had diabetes for 
five years, all patients over the age of 30, and any patient with visual symptoms or 
abnormalities. Laboratory examination guidelines includes a hemoglobin AlC
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determination a least quarterly in all insulin-treated patients. Adults should be tested 
annually for levels of total cholesterol, fasting triglycerides, HDL-cholesterol, and LDL- 
cholesteroL A lipid profile should be performed on children older than two years after 
diagnosis of diabetes. If values fall within accepted values, the assessment should be 
repeated every five years. A routine urinalysis testing for the presence of microalbumin 
or the albumin/creatinine ratio should be determined annually in postpubertal patients 
who have had diabetes for five years. Special considerations include nutritional 
assessment of children and adolescents. A nutritional assessment should be performed at 
diagnosis and at least annually by a registered dietitian familiar with the nutritional needs 
of the growing child. The reassessment o f the management plan includes determination 
o f progress in meeting goals, individualized nutrition recommendations and instructions 
by a registered dietitian, control of blood glucose levels, assessment of complications, 
control of blood pressure, follow-up of referrals, and frequency of hypoglycemia. In 
addition, the patient’s knowledge of diabetes and self-management skills should be 
reassessed a least annually. Continuing education should be provided preferably by a 
certified diabetes educator. (American Diabetes Association; Clinical Practice 
Recommendations, 1995)
The ADA suggests that a complete, organized medical records system is essential 
to provide ongoing care. Records should always be accessible to the diabetes treatment 
team and organized so that they document the occurrence of the ADA guidelines and 
serve as a reminder of what should be done for the patient at the appropriate intervals. 
(American Diabetes Association: Clinical Practice Recommendations, 1995)
CHAPTER 3 
Methods
The ADA Chart Review for Patients with Tvpe 1 Diabetes
The data collected for this study were obtained through the review of medical 
charts of patients with type 1 diabetes. The specific data obtained was divided into two 
parts, 1) physician compliance with components of the ADA s continuing care guidelines 
as one measure of quality of physician care, and 2) patient information to assess specific 
epidemiological patterns of patients with type 1 diabetes.
Information regarding compliance with the 1995/1996 ADA’s “Standards of 
Medical Care for Patients with Diabetes Mellitus” included documentation of;
1. Visitation Frequency - regular visits should be scheduled for insulin- 
treated patients at least quarterly (four times/year), depending on 
achievement of treatment goals
2. Blood Pressure Check - performed at every regular diabetic visit 
(four times/year).
3. Weight Check - performed at every regular diabetic visit (four 
times/year).
4. Height Check - performed at every regular diabetic visit until maturity 
(four times/year).
5. Foot Examination - performed at every regular diabetic visit to assess 
vascular status, skin condition, and sensation (four times/year).
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6. Hemoglobin AlC - determination should be performed at least quarterly 
in all insulin-treated patients (four times per year).
7. Lipid Profile - adults with abnormal lipid profiles should be tested 
annually for total cholesterol, fasting triglycerides, HDL-cholesterol, and 
LDL-cholesterol (once per year). A lipid profile should be performed on 
children older than two years who have been diagnosed with type 1 
diabetes. A repeat assessment should be performed every five years if 
values are normal.
8. Microalbumin/Creatinine Clearance - performed annually for adults 
and in postpubertal patients who have had diabetes for five years (once 
per year).
9. Dilated Eye Referral - physicians should refer all patients with type 1 
diabetes patients over the age of 30 years and all patients age 12 and over 
who have had diabetes for five years to complete a comprehensive dilated 
eye and visual examination annually by an ophthalmologist or optometrist 
(once per year).
10. Registered Dietitian Referral - physicians should refer all children with 
type 1 diabetes for a nutritional assessment by an individual experienced 
with the nutritional needs of a growing child, preferably a registered 
dietitian at least annually (once per year).
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11. Nurse Educator Referral - knowledge of diabetes and self-management 
skills should be reassessed a least annually preferably by a Certified 
Diabetes Educator (once per year).
Patient information collected for research and epidemiological purposes included:
1. The patient’s physician.
2 . The patient’s birth date.
3. The patient’s sex
4. The date the patient was first seen at the clinic.
5. The age the patient was diagnosed with type 1 diabetes.
The participating clinic’s Medical Record’s computerized inventory was used to 
provide a list of all patients with type 1 diabetes receiving care at the participating clinic. 
The computer compiled the list by selecting every patient with a code of 250.01 
indicating a patient with type 1 diabetes. The physicians at the participating clinic 
estimated that they treat 200-300 patients with type 1 diabetes. However, the 
computerized inventory provided a list of 1150 medical chart numbers which included all 
patients coded with the number of 250.01. Such a large number of patients with type 1 
diabetes being treated at a clinic in a relatively small community would be improbable 
according to the documented prevalence of the disease in the United States. The study 
had revealed a problem with the coding system of patients with diabetes. Similarity 
between the codes for patients with type 1 (250.01) and type 2 (250.00) diabetes proved 
to be one cause of the problem; another cause was apparent unfamiliarity o f the 
differences between type 1 and type 2 diabetes. Some patient charts indicated several
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exchanges between the codes for an individual patient; a medical impossibility The 
largest cause of the problem was patients with type 2 diabetes (250.00) beginning insulin 
therapy. Many patients were coded 250.01 because of their insulin therapy status, 
regardless of the patient’s type of diabetes. In efforts to rectify the problem, meetings 
were initiated by the nurse educator to clarify the definition of each code and explain the 
problem. In regards to the study, all 1150 charts were reviewed to determine if  the 
patient had type 1 or type 2 diabetes. The criteria used to determine if the patient had 
type 1 diabetes were: diagnosis o f the patient with diabetes before the age o f 40 years 
and/or initiation of insulin therapy within the first year of diagnosis. (American Diabetes 
Association: Clinical Practice Recommendations, 1995)
The participating clinic’s name, the physician’s name and medical charts were 
kept confidential. All patients’ charts were reviewed at the participating clinic’s various 
facilities. At no time did any of the patient files leave the facilities of the participating 
clinic. The researcher signed a waiver to keep all data and the name of the participating 
clinic, physician’s names, and patient’s names confidential Random numbers were 
assigned to all physicians and patient’s files participating in the study. The lists 
identifying the random numbers with the physician’s and patient’s file numbers were 
kept separately from the data. Data were stored in a locked briefcase. The University of 
Montana’s IRB Review Board approved this project on November 17, 1997. A consent 
form was signed by all participating physicians. Every physician signed the consent form 
agreeing to the use of his/her data in aggregate form.
33
Assessment Tool Design for Physician Compliance to The ADA's Standards
The purpose of the assessment tool was to indicate physician compliance with the 
ADA’s Standards of Care to patients with type 1 diabetes for the years of 1995 and 1996. 
The retrospective assessment tool was designed to provide the information needed in a 
one-page format to simplify data collection and to allow each page to indicate one 
patient’s two year histoiy. In addition, such an assessment tool was needed to address 
the complexities of recording extremely detailed information. Some of these 
complexities the assessment tool needed to address included the need to:
1. Record epidemiological data relevant to the patient.
2. Be able to reflect a time of reference to track if  and when ADA Standards 
were being met. A time of reference would also indicate if the physician 
was following the ADA’s suggested time frame for the various standards.
3. Document when a patient was being treated by another physician
4. Distinguish a difference between completed laboratory tests and verbal 
requests made by the physician for the patient to obtain laboratory tests.
5. Document examinations performed by the physician during a single visit
6. Document when the patient was seen for a diabetic visit as opposed to a 
non-diabetic visit.
7. Document hemoglobin AlC values for the patient.
As shown in Figure 1, the retrospective assessment tool designed for this project 
addressed each of these complexities
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Patient’s ID # __
Age of Diagnosis
DOB_ 
Current Age/Scx
Mtyacian’s ID #_
Dote Ft First Seen
JAN 95 
(I)
FEB 95 
(2)
MAR 95 
(31
APR 95 
(4)
MAY 95 
(5)
JUNE 95 
(6)
JULY 95 
(7)
AUG 95 
(8)
SEPT 95 
(9)
OCT 95 
(10)
NOV 95 
(II)
DEC 95 
(12)
JAN 96 
(1)
FEB 96
(2)
MAR 96
(3)
APR 96
(4)
MAY 96
(5)
JUNE 96 
(6)
JULY 96
(7)
AUG 96 
(8)
SEPT 96 
(9)
OCT 96 
00 )
NOV 96 
01)
DEC 96 
02)
KEY
s  Djabete» , X = VW( Uimltfed to DW>ele  ̂ O » Pstieat Seen by Anotlier Plvsiciao, BF = Blood Piessun Measurancni; 
W » Weigla Measureowat. H = Heigbt MeasufaMni. F * Foot Examiralioa L « Lqiid Profile, A= Hemo^obin Ale,
M » Nficfoefiwiin. C » CreeiiDe Clearmce. E » Dilted Eye Refenel. D * DietitMn Refietrai, N * Nurae Educetor Rdbiel
# o f * ^  frtnn Jan 95 • Dec 96 CRITERIA
*95 *96
  __ Visits with Diabetes Physiciam
  __  Lipid Profiles Oabs^eqnest)
  __ HemoglobiD A lC  (labsAeqnest)
    Microalbiiiiiiii/OeatiDe Cleannoe (bbsAoqoest)
  __ Dilated Eye Refoials
  __ Registered Dietitiaii Refenals
  ___ Norse Edacator Refenals
,  ___ Foot Exaatinaiioos
  __  Blood Pressure Measurements
  __  Weight Measuranenls
  __  Height Measurements (until maturity)
% M et
Visitation - 4lim es per year
Lqnd Profile - Yearly (CfaUd - after age 2 yrs, rq»eat 
every 5 yis if  normal)
Hemoglolmi A le - Quarterly (every 3 mondis)
Microalbamiii/CrcatiiieClearance — Yearly -post- 
pubertal patient who has had diabetes for 5 Yrs
Dilated Eye Referral - Yearfy for pt over 12yrsn*o 
has had diabetes for 5 years, all pts over 30 yrs
Roistered Dietitian Refenal (Child — Yearly)
Nurse Educator Referral
Foot Exarninatkm - Every Regular Visit
Blood Piessute Measurements • Every Regular Visit
W e i^  Measurements - Every Regular Visit
HergW Measurements(mrtil m aturity)- Every Regular 
Visit
Conunents:
EtgUfff ,T I Retrospective assessment tool designed to assess physician compliance to the 
ADA Standards.
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The top section of the assessment tool allows for epidemiological data to be 
recorded for each patient with type 1 diabetes. The middle section of the assessment tool 
makes it possible to record detailed information regarding each visit by using the key 
provided. In addition, the middle section of the assessment tool provides a frame of 
reference by allowing information to be recorded on a month to month basis. The lines 
provided below each month indicate a single visit; the key is used to record what 
occurred during the visit. The key also addresses the issues o f a diabetes related visit 
versus a non-diabetes related visit, when the patient was being treated by another 
physician, and the difference between a completed lab test and a verbal request. The 
bottom section of the assessment tool allows for the frequency and percent values of each 
of the ADA Standards to be recorded for 1995 and 1996.
Statistical Analysis of Data
Measures of central tendency and frequencies were used to assess physician 
compliance to the ADA’s Standards. Aggregate data were used to demonstrate how 
effective the main clinic and the satellite clinics were at meeting these standards for 1995 
and 1996.
The data collected on physician compliance with the ADA’s Standards of Care 
were analyzed accordingly .
1. Measures of central tendency and percents were determined using
aggregate data for physician compliance with each ADA Standard. This 
information is provided for the main clinic and the satellite clinics.
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2. Mean hemoglobin AlC values were determined for the main clinic
and satellite clinics.
Several comparisons were made from the statistical analysis of data. Some 
demographic comparisons were made among physicians regarding physician gender and 
the number of patients with type I diabetes each physician treated in 1995 and 1996.
The comparisons included:
1. Comparisons were made between the main clinic and the satellite clinics’ 
physician compliance with the ADA Standards using measures of central 
tendency and percents for each ADA Standard.
2. Comparisons were made between physician compliance to the ADA 
Standards for children and adult patients with type I diabetes using 
measures of central tendency and percents for each ADA Standard at the 
main clinic and satellite clinics.
3. Comparisons were made between male and female physicians’ 
compliance to the ADA Standards using measures of central tendency and 
percents for each ADA Standard at the main clinic This comparison was 
not performed at the satellite clinics because all physicians were male.
4. Comparisons were made between physicians treating 10 or more patients 
with type I diabetes and physicians treating fewer than 10 patients with 
type I diabetes using measures of central tendency and percents for each 
ADA Standard at the main clinic. This comparison was not performed at 
the satellite clinics because all physicians treated fewer than four patients.
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5. All sample groups’ mean hemoglobin A lC values were compared to the 
ADA and DCCT recommended mean hemoglobin A lC value of 7.2%.
6. Comparisons were made between each sample group’s mean hemoglobin 
AlC values and physician compliance to the visitation frequency standard 
and the hemoglobin A lC determination standard. These two standards 
are essential for optimal quality care. The visitation frequency standard 
allows a physician to develop a relationship with the patient; making the 
physician more accountable for that patient. The hemoglobin A lC 
determination standard is the only laboratory test that is diabetes specific. 
The frequency of the hemoglobin AlC laboratory test allows the physician 
to ascertain the patient’s diabetes status and also gives the physician a 
reason to take a more active role in the care o f their patient. Higher 
compliance with ADA Standards may favorably influence hemoglobin 
AlC values.
Mean values are provided for the epidemiological data collected on the patients 
with type 1 diabetes at the participating clinic. These included.
1. Age - This information was compared to the average age of patients with 
type 1 diabetes in the United States
2. Age of onset - This information was compared to the average age of onset 
for patients with type 1 diabetes in the United States.
3. Duration of type 1 diabetes - This information was compared to the 
national average of the duration of type 1 diabetes.
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4 Sex - This information was compared to the percent of male and female 
patients with type 1 diabetes in the United States.
CHAPTER 4 
Results
Description of Sample - Main Clinic and Satellite Clinics 
Nineteen physicians treated the population of patients with type 1 diabetes at the 
main clinic. Twelve physicians treated adult patients with type 1 diabetes, five 
physicians treated children with type 1 diabetes (less than age IS), and two treated a 
combination of adults and children. Each main clinic physician treated a varying number 
of patients with type 1 diabetes ranging from 1 to 43 patients. Sixteen of these 
physicians treated fewer than 10 patients with type 1 diabetes and three physicians 
treated 10 or more patients with type 1 diabetes. Seven of the main clinic’s physicians 
included in the study are female; twelve are male.
The satellite clinics included nine physicians having treated a small population of 
patients with type 1 diabetes. Five of these physicians treated adult patients with type 1 
diabetes, one physician treated children with type 1 diabetes, and three treated a 
combination of adults and children. The greatest number o f patients with type 1 diabetes 
treated by one satellite clinic physician was four, with the majority of physicians having 
treated one patient with type 1 diabetes. All of the satellite physicians included in this 
study were male.
Sample groups included.
1. Main Clinic :
19 physicians treated the population of patients with type 1 diabetes at the main 
clinic which included 107 medical charts in 1995 and 122 medical charts in 1996.
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2. Care Provided to Adults with Type I Diabetes - Main Clinic :
14 physicians treated adults with type 1 diabetes at the main clinic which 
included 91 medical charts in 1995 and 104 medical charts in 1996 (12 
physicians treated only adults with type 1 diabetes; two treated adults and 
children with type 1 diabetes).
3. Care Provided to Children with Type 1 Diabetes - Main Clinic ;
Seven physicians treated the children with type 1 diabetes at the main clinic 
which included 16 medical charts in 1995 and 18 medical charts in 1996 (five 
physicians treated only children with type 1 diabetes; two treated adults and 
children with type 1 diabetes).
4. Female Physicians - Main Clinic :
Seven female physicians treated a segment of the patients with type 1 diabetes at 
the main clinic which included 17 medical charts in 1995 and 20 medical charts 
in 1996.
5. Male Physicians - Main Clinic .
12 male physicians treated a segment of the patients with type 1 diabetes at the
main clinic which included 90 medical charts in 1995 and 102 medical charts in 
1996.
6. Physicians Treating 10 or More Patients with Type 1 Diabetes - Main Clinic :
Three physicians treated 10 or more patients with type 1 diabetes at the main 
clinic which included 74 medical charts in 1995 and 83 medical charts in 1996.
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7. Physicians Treating Fewer Than 10 Patients with Type 1 Diabetes - Main Clinic :
16 physicians treated fewer than 10 patients with type 1 diabetes at the main 
clinic which included 33 medical charts in 1995 and 39 medical charts in 1996.
8. Satellite Clinics ;
Nine physicians at both Satellite Clinics treated the population of patients with 
type 1 diabetes treated at the satellite clinics which included 15 medical charts in 
1995 and 16 medical charts in 1996.
9. Care Provided to Adults with Type 1 Diabetes - Satellite Clinics :
Eight physicians treated the adults with type 1 diabetes at the satellite clinics 
which included 11 medical charts in 1995 and 12 medical charts in 1996 (five 
physicians treated only adults with type 1 diabetes; three treated adults and 
children with type 1 diabetes).
10. Care Provided to Children with Type 1 Diabetes - Satellite Clinics :
Four physicians treated the children with type 1 diabetes at the satellite clinics
which included four medical charts in 1995 and four medical charts in 1996 (one
physician treated only children with type 1 diabetes; three treated adults and 
children with type 1 diabetes).
The number of charts analyzed varied according to the specific requirements of 
certain ADA Standards. For example, the requirement for a dilated eye referral is all 
patients with type 1 diabetes older than 12 years whom have had diabetes for five years, 
and all patients older than 30 years. Those physicians whose patients’ charts did not 
meet these requirements were exempt from the dilated eye referral standard. The ADA
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Standards that have unique requirements are height measurement, lipid profile, dilated 
eye referral, microalbumin/creatinine clearance referrals, and dietitian referrals. Each 
medical chart of a patient with type 1 diabetes was considered for these unique 
requirements for 1995 and 1996. Complete analysis of the data is located in Appendixes 
A through V. A short summary of the data analysis is provided in the following sections 
for each ADA Standard.
Visitation Frequency 
Physicians treating more than 10 patients with type 1 diabetes had the 
highest compliance to the visitation frequency standard at 44.6% in 1995 (see Table 1). 
All other physician sample groups had lower compliance to the visitation standard, with 
physicians treating children with type 1 diabetes at the satellite clinics having the lowest 
compliance at 0.0% in 1996. Mode values for all sample groups, not including adults 
treated at the satellite clinics in 1995 (bimodal=l and 3) or children treated at the main 
clinic in 1996 (mode=2), were 0 and/or 1.
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Table 1
1995/1996 Visitation Standard Results
Sample Group
Main Ctinîc ResuKs • AI) Patients w/ Type 1 Diabetes
Main Cfinic - Adult Patients wf Type 1 Diabetes
Main Clinic - Ct«itd Patients w/ Type 1 Diebeles
Main Clinic - Female Ptiysieians
Main Clinic • Mate Physicians
Main Clinic - Physicians Treating >10 PMiewts  W Type 1 Oiebeies
Mam Clinic - Physiciens Treating <10 Patients w/ Type 1 Diabetes
Satellite Clinics' Results - Alt Patients ml Type 1 Diabetes
Satellite Clinics - Adult Patients vtf Type 1 Diabetes
Satellite CRnios - Child Patients w/ Type 1 Diabetes
1995
#
or
cherts
Mode
%meelirtg/
exceeding
Standard
107 1 41.1
91 1 44.0
16 1 26.7
17 0 and 1 235
90 1 44.4
74 1 44.6
33 1 33.3
15 0 and 1 26.7
11 1 and 3 27.3
4 0 250
1996
«
of
charts
Mode
%meebnQ/
exceeding
Standard
122 1 36.9
104 1 394
18 2 22.2
20 1 40.0
102 1 363
83 1 398
39 1 308
16 0 12.5
12 0 16.7
4 1 00
Blood Pressure Measurement Standard 
Physicians treating more than 10 patients with type 1 diabetes had the highest 
compliance to the blood pressure measurement standard at 40.5% in 1995 (see Table 2). 
Physicians treating children with type 1 diabetes at the satellite clinics in 1995 and 1996 
and the main clinic in 1996 had the lowest compliance to the blood pressure 
measurement standard at 0.0%. All physician sample groups treating patients at the main 
clinic (1995 and 1996) and physicians treating adults at the satellite clinics in 1995 had a 
mode of 1. The remaining satellite sample groups had a mode of 0.
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Table 2
19S5/1996 Blood Pressure Measurement Standard Results
1995
Sample Group
Main Clinic Results - Ml Patierrts w/ Type 1 Diabetes
Main Clinic • Adult Patients v#/ Type 1 Diabetes
Mam Clinic • CtilW Patients vnf Type 1 Dtatietes
Main Clinic - Female Ptiysieians
Main Clinic - tidal* Ptiysieians
Mam Clinic - Ptiysieians Tieating >10 Patients w/ Type 1 Oiatietes
Main Clinic - Ptiysieians Treatinp *10 Patients w/ Type 1 Ombeies
Satellite Clinics’ Results - Ml Patie nts  Ytl Type 1 Oiatietes
Salellila Clinics - Adult Patients vwi Type 1 Diabetes
Satellite Clinics • Child Patients wl Type 1 Diabetes
#
of
ctiarts
Mod*
% mooting/ 
«lŒMding 
Standard
107 1 34.6
91 1 39,6
16 1 6.3
17 1 23.5
90 1 36.7
74 1 405
33 1 21.2
15 0 20.0
11 1 27.3
4 0 0.0
1996
f
of
charts
Mode
%m*cbno/
•xceeding
Standard
122 1 29.5
104 1 346
18 1 0.0
20 1 25.0
102 1 304
83 1 34.0
39 1 17.9
16 0 6.3
12 0 8.3
4 0 0.0
Weight Measurement Standard 
Physicians treating more than 10 patients with type 1 diabetes had the highest 
compliance to the weight measurement standard at 35.1% in 1995 (see Table 3). All 
other physician sample groups had a lower compliance, with the physicians treating 
children at the satellite clinics having the lowest compliance at 0.0% in 1995 and 1996. 
In 1995 and 1996 modes for all sample groups, not including all satellite sample groups 
(mode=0) and female physicians (bimodalK) and 1, 1995 only), were 1
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Table 3
1995/1996_Weight Measurement Standard Results
1995
Sample Group
Maki Clinic Results - All Ratients w/ Type 1 Diabetes
Main Clinic • Adult Patients w/ Type 1 Oiatietes
Main Clinic - Ctiitd Patients wl Type 1 Diabetes
Main Clinic - Female Ptiysieians
Main Clinic - Male Ptiysieians
Main Clinic - PliysicianB Treating > 10 Parents w/ type 1 OiatMles
Meki Clinic - Ptiysieians Treating <10 Patients w/ Type 1 Diabetes
SateUMe Clinics' Results - All Patients w/ Type 1 Diatietes
SateHke CtkiioG - Aduh Pabents W Type 1 Oiatietes
Satellite Clinics • Ctilld Patients w/ Type 1 Oiatieles
«
or
charts
Mode
%meebng/
exceeding
Standard
107 1 30.8
91 1 34.1
16 1 12.5
17 0 and 1 23 5
90 1 322
74 1 3S.1
33 1 21.2
15 0 133
11 0 18.2
4 0 0.0
1996
«
of
ctiarts
Mode
% meeting/ 
exceeding 
Standard
122 1 28.7
104 1 32.7
18 1 5.6
20 1 200
102 1 304
83 1 33.7
39 1 17.9
16 0 6.3
12 0 8.3
4 0 0.0
Height Measurement Standard 
The ADA recommendation for the height measurement standard was not met by 
any of the sample groups in 1995 and 1996 (see Table 4). Only physicians treating 
children with type 1 diabetes were accountable for this standard due to the ADA 
stipulation “until the age o f maturity.” Mode value was 0 in most sample groups with the 
exceptions of female physician (mode=l) in 1995, physicians treating more than 10 
patients with type 1 diabetes (mode=l) in 1995, and physicians treating fewer than 10 
patients with type 1 diabetes (bimodal=0 and 1) in 1996.
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Table 4
1995/1996 Height Measurement Standard Results
1995
Sample Group
Main Clinic Results • All Patients w/ Type 1 Dialwtes
Main Clinic • Adult Patients vtt Type 1 Diabetes
Main Clinic • Ctiitd Patients w/ Type 1 Diabetes
Main Clinic * Female Ptiysieians
Main Clinic • Male PItyaicians
Main Clinic • Ptiysieians Treating >10 Patients w/ Type 1 Dialtetes
Main Clinic • Ptiysiciens Treating <10 Patients w/ Type 1 Dialietee
Satellite Clinics' Results • Ml Pabents w/ Type 1 Dialtetes
Satellite Clinics • Adult Patients w/ Type 1 Ratietes
Satellite Cbnios - Child Patients wl Type 1 Diabetes
«
of
charts
Mode
%mee(ino/
exceeding
Standard
16 0 0.0
n/a n/a n/a
16 0 0.0
6 1 0.0
10 0 0 0
1 1 0.0
15 0 0.0
4 0 0 0
n/a n/a n/a
4 0 0.0
1996
#
of
charts
Mode
% meeting/ 
exceeding 
Standard
20 0 0.0
n/a n/a n/a
18 0 0.0
7 0 0 0
13 0 0.0
3 0 0.0
17 0 and 1 0.0
4 0 0.0
n/a n/a n/a
4 0 0.0
Foot Examination Standard 
Physicians treating fewer than 10 patients with type 1 diabetes had the highest 
compliance to the foot examination standard at 6.1% in 1995 (see Table 5). All other 
physician sample groups had lower compliance A virtual lack of compliance was seen 
in five of the sample groups in 1995 and four sample groups in 1996 Most sample 
groups had mode values of 0, exceptions included 1996 results for the main clinic, 
physicians treating adults at the main clinic, male physicians, and physicians treating 
more than 10 patients with type 1 diabetes with a mode value of 1.
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Table 5
1995/1996 Foot Examination Standard Results
Sample Group
Main Clinic Results - Ail Patients w/ Type 1 Oiobetaa
Main Clinic • AduM Patients w/ Type 1 Diatietes
Main Clinic • ChWd Pabents w/ Type 1 Diatietes
Main Clinic - Female Physiciens
Main Clmic - Male Physicians
Main Clinic - Physicians Treating >10 Patients W Type 1 Diatietes
Main Clinic - Physicians Treating <10 Patients w/ Type 1 Diatietes
GateHile Clinics' Results • All Patients wf Type 1 Diatietes
SateHile Clinics • AduK Patients wf Type 1 Oiatieles
Satellite Clinics - Child Patients w/ Type 1 Diabetes
1995
#
df
charts
Mode
% meeting/ 
exoeeding 
Standard
107 0 3 7
91 0 4.4
16 0 0.0
17 0 0.0
90 0 4 4
33 0 6.1
îé 6 se
11 0 0 0
4 0 0.0
1996
«
of
charts
Mode
% meeting/ 
exceeding 
Standard
122 1 3.3
104 1 3 8
18 0 0 0
20 0 5.0
102 1 2.9
39 0 2.6
H A
12 0 0.0
4 0 0.0
Hemoglobin A lC Determination Standard 
Physicians treating more than 10 patients with type 1 diabetes had the highest 
compliance to the hemoglobin A lC determination standard at 15.7% in 1996 (see Table 
6). All other physician sample groups had lower compliance to the hemoglobin AlC 
determination standard. The physician sample groups at the satellite clinics in 1995 and 
1996 and the children treated at the main clinic in 1995 had the lowest compliance to the 
hemoglobin AlC determination standard at 0,0%. Most sample groups had a mode value 
of 1 with the exceptions of all satellite clinics with a mode value of 0 and physicians 
treating children with a bimodal result of 1 and 2.
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Table 6
1995/1996 Hemoglobin AlC Determination Standard Results
1995
Sample Group
Main Clinic Rasutts - All Patienta w/ Type 1 Diabetes
Main Clinic - Adult Patients w/ Type 1 Diabetes
Mam Clinic - Child Pabents w/ Type 1 Diabetes
Main Clinic • Female Physiciens
Main Clinic - Male Physicians
Main Clinic - Physicians Treobng >10 Pabents w/ Type 1 Diabetes
Main Clinic - Ptiysieians Tieabng <10 Pabents wrf Type 1 Diabetes
Satellite Clinics' Results - All Pabents w/ Type 1 Diabetes
Satellite CNnics - Adult Patients w/ Type 1 Diatteles
Satellite Clinics • Child Patients w/ Type 1 Diatwtes
#
of
charts
Mode
% meebngf 
exceeding 
Standard
107 1 8.4
91 1 9.9
16 1 and 2 0.0
17 1 5.9
90 1 89
74 1 8.1
33 1 9.1
15 0 0.0
11 0 0.0
4 0 0.0
1996
»
of
charts
Mode
%fneetmgf
exceeding
Standard
122 1 13.1
104 1 14.4
18 1 5.6
20 1 5 0
102 1 14.7
83 1 15.7
39 1 7,7
16 0 0.0
12 0 0.0
4 0 0.0
Lipid Profile Standard 
Compliance with the lipid profile standard was met at a greater percentage than 
all other standards (see Table 7). The ADA recommends a lipid profile annually for all 
adult patients with type 1 diabetes who have abnormal lipid profiles. Physicians treating 
fewer than 10 patients with type 1 diabetes had the highest compliance with the lipid 
profile standard at 81.0% in 1996. All other physician sample groups had a lower 
compliance to the lipid profile standard with the physicians at the satellite clinics in 1996 
having had the lowest compliance at 33.3%. High compliance with this standard was 
verified with a mode value of 1 for most sample groups with the exception o f the satellite 
clinics and the female physicians in 1995 with a mode value of 0. Physicians treating 
children with type 1 diabetes were not accountable for the lipid profile standard due to 
the ADA stipulation “if normal, an assessment should be repeated in five years.”
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Table 7
1995/1996 Lipid Profile Determination Standard Results
1995
Sample Group
Main Clinic Results - AU Pabents ««/ Type 1 Diabetes
Main Clinic • AduK Patients wf Type 1 Diabetes
Main Clinic • Child Patients wf Type 1 Dialietee
Main Clinic - Female Physicians
Mein Clinic - Male Physicians
Main Clinic - Physicians Tieating >10 Pabents vH Type 1 Diabetes
Main Clinic - Miysidams Tieabng <10 Pabents w/ Type 1 Diatieles
SeleNile Clinics’ Results - All Pabents w/ Type 1 Diabetes
SatelMe Clinics - AduK Patients wf Type 1 Oiatietes
SateUKe Clinics - Ctiitd Patients vd Type 1 Oia tMtos
«
of
charts
Mode
%meebngf
exceeding
Standard
91 1 67.0
91 1 67.0
n/a n/a n/a
11 0 45.5
80 1 68.8
73 1 69.9
18 0 55.6
11 0 36.4
11 0 364
n/a n/a n/a
1996
»
of
ctiarts
Mode
% meebng/ 
exceeding 
Standard
101 1 70.3
101 1 703
n/a n/a n/a
12 1 75.0
89 1 68.5
80 1 68.8
21 1 81.0
12 0 333
12 0 33 3
n/a n/a n/a
Microalbumin/Creatinine Clearance Determination Standard 
Physicians treating more than 10 patients with type 1 diabetes had the highest 
compliance with the microalbumin/creatinine clearance determination standard at 68.8% 
in 1996 (see Table 8). All other physician sample groups had lower compliance results. 
The 1995 results for all satellite clinics sample groups and physicians treating children at 
the satellite clinics in 1996 had the lowest compliance to the microalbumin/creatinine 
clearance standard at 0.0%. Most sample groups had a mode value of 0 for 1995 and 
1996. The exceptions were 1996 results for the main clinic, physicians treating adults, 
male physicians, and physicians treating more than 10 patients with type 1 diabetes with 
a mode value of 1.
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Table 8
1995/1996 Microalbumin/Creatinine Clearance Determination Standard Results
Sample Group
Main Clinic ResuMs • All Patwnls W Type 1 Oiabeles
Main Clinic • Adult Patients W  Type 1 Diabetes
Main Clinic - Child Patients w/ Type 1 Diabetes
Main Clinic - Female Ptiysieians
Main Clinic • Male Physicians
Main Clinic - Ptiysieians Treating >10 Patients vw/ Type 1 Dialieles
Main Clinic - Physicians Treating <10 Patients vwi Type 1 Diatietes
Satellite Clinics Results - All Patients wf Type 1 Diatwles
Satellite CHnics • Adult Patients yri Type 1 OialMtes
Satellite Clinics • Child Pabents  W Type 1 Diatietes
1995
#
of
ctiarts
Mode
% meeting/ 
exceeding 
Standard
91 0 51.6
86 0 52.3
5 0 40.0
12 0 41.7
79 0 53.2
70 0 529
21 0 47.6
12 0 0.0
11 0 0.0
1 0 0.0
1996
#
of
charts
Mode
% meeting/ 
exceeding 
Standard
103 1 63.1
99 1 64 6
4 0 25 0
13 0 538
90 1 64 4
77 1 66 8
26 0 462
13 0 23.1
12 0 25.0
1 0 0.0
Dilated Eve Referral Standard 
Physician compliance to the dilated eye referral standard (see Table 9) ranged 
from 66.7% in 1995 for physicians treating children with type 1 diabetes to 0.0% for 
physicians treating children at the satellite clinics (1995) and all satellite clinics’ sample 
groups (1996). Mode value for all sample groups, not including physicians treating 
children with type 1 diabetes at the main clinic (mode=l), was 0.
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Table 9
1995/1996 Dilated Eve Referral Standard Results
1995
Sample Group
Main Clinic Results • All Patiems w/ Type 1 Diabetes
Mam Clinic - Adult Patients w/ Type 1 Diabetes
Main Clinic -  Child Patients w/ Type 1 Diabetes
Main Clinic • Female Physicians
Main Clinic - Male Ptiysieians
Main Clinio • Physicians Treating >10 Patients *tf Type 1 Diabetes
lAain Clinio - Ptiysieians Treating <10 Patients W  Type 1 Diatieles
Satellite Clinics' Results - All Patients w/ Type 1 Diatietes
Satellite Clinics - Adult Patients w/ Type 1 Diatietes
Satellite Clinics - Child Patients w/ Type 1 Diatietes
#
of
charts
Mode
% meetihg/ 
exceeding 
Standard
94 0 45.7
86 0 44.3
6 1 667
13 0 30.6
81 0 481
70 0 45.7
24 0 45 8
12 0 16.7
11 0 16.2
1 0 0.0
1996
»
of
charts
Mode
% meeting/ 
exceeding 
Standard
107 0 44.9
99 0 465
8 0 25 0
15 0 46.7
92 0 44.6
77 0 481
30 0 36.7
13 0 0.0
12 0 0.0
2 0 0 0
Dietitian Referral Standard 
In 1996 higher compliance was demonstrated in physicians treating more than 10 
patients with type 1 diabetes and physicians treating adult patients at the main clinic, 
however, it must be noted these results only included one medical chart (see Table 10). 
All other physician sample groups had lower compliance to the dietitian referral standard 
with three sample groups in 1995 having 0.0% compliance. All mode values in 1995 
were 0. Mode values varied in 1996 from 0, 2, 0 and 2, and 7.
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Table 10
1995/1996 Dietitian Referral Standard Results
Sample Group
Main Clinic Reaults • All Patients w/ Type 1 Diabeles
Main Clinic - AduH Patients w/ Type 1 Oiatietes
Main Clinic • Child Patients w/ Type 1 CKatietes
Main Clinic • Female Physicians
Main Clinic • Male Physicians
Main Clinic - Physicians Tfeehng >10 Patients W Type 1 D»betee
Main Clinic - Ptiysieians Treating <10 Patients w/ Type 1 Oiatieles
SateHile Clinics' Results • All Patients w/ Type 1 Oiattetes
Satellite Clinics - Adult Patients wf Type 1 Dialieles
Satellite Clinics - Child Patients W  Type 1 Oiatwlss
1995
#
of
charts
Mode
% meeting/ 
exceeding 
Standard
16 0 43,8
n/a n/a n/a
16 0 43 8
6 0 66.7
10 0 30,0
1 0 00
15 0 46,7
4 0 00
n/a n/a n/a
4 0 0,0
1996
«
of
charts
Mode
% meeting/ 
exceeding 
Standard
19 0 73.7
1 7 100.0
18 0 72.2
7 2 71.4
12 0 and 2 75.0
1 7 100.0
17 0 and 2 76.5
4 0 25.0
n/a n/a n/a
4 0 25.0
Nurse Educator Referral Standard 
Female physicians had the highest compliance to the nurse educator referral 
standard at 50,0% in 1996 (see Table 11). All other physician sample groups had lower 
compliance results. Satellite physician sample groups in 1995 had the lowest compliance 
to the nurse educator referral standard at 0.0%. Mode value for all sample groups was 0.
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Table 11
1995/1996 Nurse Educator Referral Standard Results
1995
Sample Group
Main Clinic Rmulls • AU Patients w/ Type 1 Diabetes
Main Clinic - AduM Patients w/ Type 1 Diabetes
Main Clinic • Cfwld Patients W  Type 1 Diabeles
Main Clinic - Female PIvysictans
Main Clinic • Male Physicians
Main Clinic - Ptiysiâans T reeling >10 Patients w/ type 1 Diabetes
Main Clinic - Physicians Treating <10 Patients w/ Type 1 Oiatietes
Satellite Clinics' Results - All Patients w/ Type 1 Dialtetes
Satellite Clinics • Adult Patients w/ Type 1 Diatwies
Satellite Clinics - Child Patients w/ Type 1 Diabetes
«
of
charts
Mod*
^meeting/
«xcaeding
Standard
107 0 15.0
91 0 11.0
16 0 37.5
17 0 47.1
90 0 8 9
74 0 6.1
33 0 30.3
16 0 0.0
11 0 0.0
4 0 0.0
1996
*
of
charts
Mode
%m*oting/
excaedino
Standard
122 0 36 1
104 0 31 7
18 0 61.1
20 0 50 0
102 0 34.3
83 0 36.1
39 0 38.5
16 0 12.5
12 0 8.3
4 0 25.0
Hemoglobin AlC Results
Results for 1995
Normal hemoglobin A lC values range from 4.0-6.0%. The DCCT has shown a 
delay in the onset and a major slowing in the progression of long-term complications 
with a mean hemoglobin A lC value of 7.2%. The mean hemoglobin A lC value for the 
main clinic, including all physicians, was 8.4%. Mean hemoglobin AlC values for adults 
with type 1 diabetes and children with type 1 diabetes were 8.3% and 8.9%, respectively. 
Male physician mean hemoglobin A lC value and female physician mean hemoglobin 
AlC value were 8.5% and 7.4%, respectively. Mean hemoglobin AlC values for 
physicians treating more than 10 patients with type 1 diabetes and physicians treating 
fewer than 10 patients with type 1 diabetes were 8.5% and 8.1%, respectively. The mean 
hemoglobin A lC  value for the satellite clinic, including all physicians was 7.9%.
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Satellite adults with type 1 diabetes mean hemoglobin AlC was 7.9%, a mean 
hemoglobin for children with type 1 diabetes was not available due to lack of laboratory 
analysis. (See Appendix U for a complete analysis.)
Results for 1996
The mean hemoglobin A lC value for the main clinic, including all physicians 
was 8.7%. Mean hemoglobin A lC values for adults with type 1 diabetes and children 
with type 1 diabetes were 8.6% and 9.7% respectively. Male physician mean 
hemoglobin A lC value and female physician mean hemoglobin A lC  value were 8.8% 
and 8.1%, respectively. Mean hemoglobin A lC values for physicians treating more than 
10 patients with type 1 diabetes and physicians treating fewer than 10 patients with type 
1 diabetes were 8.7% and 8.6%, respectively. The mean hemoglobin A lC value for the 
satellite clinic, including all physicians was 9.7%. Mean hemoglobin for satellite adults 
with type 1 diabetes and satellite children with type 1 diabetes was 9.8% and 9.5, 
respectively. (See Appendix U for a complete analysis.)
Epidemiologies Results 
Cowie and Harris reported the median age among persons with type 1 diabetes in 
the United States older than 18 is 32 years, A study performed in Allegheny County, PA 
between the years of 1965-89 showed an age range of 0-44 years among persons with 
type 1 diabetes with most patients with type 1 diabetes between the ages of 25-29.
(Cowie & Harris, 1995) The average age of adults with type I diabetes at the main clinic 
and satellite clinics was 41.19 years (42.92 years - main clinic, 45.50 years - satellite
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clinics). The average age of children with type 1 diabetes at the main clinic and satellite 
clinics was 12.86 years (13.11 years - main clinic, 11.75 years - satellite clinics). The 
average age of the entire sample of patients with type 1 diabetes at the main clinic and 
satellite clinics was 36.77 years (36.74 years - main clinic, 37.06 years - satellite clinics). 
(See Appendix V for a complete analysis.)
In the United States onset of type 1 diabetes is most frequent at age 10-14 years, 
during the pubertal peak. (Cowie & Harris, 1995; LaPorte, 1995) The average age of 
onset for patients with type 1 diabetes at the main clinic and satellite clinics was 16.48 
years (16.36 years - main clinic, 17.57 years - satellite clinics). The average age o f onset 
for children at the main clinic and satellite clinics was 6.64 years (7.00 years - main 
clinic, 5.00 years - satellite clinics). The average age of onset for adults at the main 
clinic and satellite clinics was 18.42 years (18.01 years - main clinic, 27.10 years - 
satellite clinics). (See Appendix W for a complete analysis.)
Studies performed in Allegheny County, PA showed that duration (the length of 
time a patient has had type 1 diabetes) of type 1 diabetes is evenly distributed between 0- 
24 years. (Cowie & Harris, 1995) The average duration o f type 1 diabetes for the type 1 
diabetes patient sample at the main clinic and satellite clinics was 19.99 years (20.25 
years - main clinic, 17.79 years - satellite clinics). The average duration of type 1 
diabetes for children at the main clinic and satellite clinics was 6.23 years (6.11 years - 
main clinic, 6.75 years - satellite clinics). The average duration of type 1 diabetes for 
adults at the main clinic and satellite clinics was 22.70 years (22.75 years - main clinic, 
22.20 years - satellite clinics). (See Appendix X for a complete analysis.)
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In the United States studies indicate that there are slightly more white males 
(53.4%) older than 18 with type 1 diabetes than white females (46.6%) older than 18. 
(Haire-Joshu, 1996) The percent of male/female patients with type 1 diabetes at the 
main clinic and satellite clinics was 55.3% (n = 78) male and 44.4% (n = 63) female.
The percent of male/female patients with type I diabetes at the main clinic was 53,6% (n 
= 67) male and 45.4% (n = 58) female. The percent of male/female patients with type 1 
diabetes at satellite clinics was 68.8% (n = 11) male and 31.2% (n = 5) female. The 
percent of male/female children with type 1 diabetes at the main clinic and satellite 
clinics was 72.7% (n = 16) male and 27.3% (n = 6) female. The percent of male/female 
children with type 1 diabetes at the main clinic was 66.7% (n = 12) male and 33.3% (n = 
6) female. The percent of male/female children with type 1 diabetes at satellite clinics is 
100% (n = 4) male and 0.0% (n = 0) female. The percent o f male/female adults with 
type 1 diabetes at the main clinic and satellite clinics was 52.1% (n = 62) male and 
47.9% (n = 57) female. The percent of male/female adults with type 1 diabetes at the 
main clinic was 51.4% (n = 55) male and 48.6% (n = 52) female. The percent of 
male/female adults with type 1 diabetes at satellite clinics was 58.3% (n = 7) male and 
41.7% (n = 5) female. (See Appendix U for a complete analysis.)
CHAPTERS 
Discussion and Recommendations 
Discussion
Effectiveness of the Assessment Tool
The assessment tool designed for this project allowed the researcher to collect 
accurate and detailed information from charts of patients with type 1 diabetes. Using a 
time line made it visually possible to ascertain if  a patient was receiving optimal or less 
than optimal care as shown in Table 12 and Table 13. The key made it possible to 
accurately state in specific detail physicians’ compliance to the ADA Standards.
Table 12
Example of Optimal Care
Jan
(1)
Feb
(2)
Mar
(3)
Apr
(4)
May
(5)
June
(6)
July
(7)
Aug
(S)
Sep
(9)
Oct
(10)
Nov
(111
Dec
(12)
A AML A A
Key : b= Diabetic Visit, X = Visit Unrelated to Diabetes, O = Patient Seen by Other 
Physician, L= Lipid Profile, A = Hemoglobin AlC, M = Microalbumin, C = Creatinine 
Clearance, E = Dilated Eye Referral, D = Dietitian Referral, N = Nurse Educator 
Referral, F = Foot Exam, BP = Blood Pressure Measurement, W = Weight Measurement, 
H= Height Measurement
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Table 13
Example o f Less than Optimal Care
Jan
(U
Feb
( 2 )
Mar
(31
Apr
(4 )
May
(5)
June
(6) _
July
(7)
Aug
(6)
Sep
(9)
Oct
(10)
Nov
M11
Dec
(12)
/a p y  BP 10 X U J P
Key : = Diabetic Visit, X = Visit Unrelated to Diabetes, O = Patient Seen by Other
Physician, L= Lipid Profile, A = Hemoglobin AlC, M = Microalbumin, C = Creatinine 
Clearance, E -  Dilated Eye Referral, D — Dietitian Referral, N = Nurse Educator 
Referral, F = Foot Exam, BP = Blood Pressure Measurement, W = Weight Measurement, 
H= Height Measurement
In addition, the assessment tool allowed the researcher to count the frequency 
adherence of each standard and to represent in percentage form physicians’ compliance 
to the ADA Standards. The comment section o f the assessment tool proved to be 
valuable because it allowed important information to be recorded such as hemoglobin 
AlC values and compliance problems with patients. One measure of effectiveness was 
demonstrated with the detailed analyses of the data (Appendices A-X). Further 
verification could be shown with physician use.
Impact of the Visitation Frequency Standard
The researcher determined that the visitation frequency standard is the key to 
physician compliance to all other standards. Simply stated, the ADA Standards cannot 
be performed for a patient with type 1 diabetes if the patient is not seen at the clinic for 
an appointment. Blood pressure, weight and height measurements, and foot 
examinations are all standards performed during the type 1 diabetic visit. These
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standards are controlled by patient visitation frequency. Analysis of the data showed 
these standards could only be met up to the percentage value for the visitation standard 
Despite the control of the visitation standard, the data indicated for the majority of 
sample groups blood pressure, weight, height, and foot examinations were met at a lower 
percentage than the visitation frequency standard. This demonstrates that blood pressure, 
weight, height, and foot examinations were not performed during all patient visits. In all 
sample groups, higher compliance to the blood pressure measurement and weight 
measurement standards were seen compared to the height measurement and foot 
examination standards. In fact, in all sample groups the height measurement standard 
was never met; the highest compliance to the foot examination standard was 6.1% 
(physicians treating fewer than 10 patients - 1995).
The hemoglobin AIC determination standard is also controlled by visitation and 
can only be met up to the percentage value for the visitation standard. However, the data 
indicated compliance with the hemoglobin AlC determination standard was much lower 
than compliance to the visitation standard. This demonstrates that the physicians did not 
verbally state that a hemoglobin A lC was needed during all patient visits. The highest 
compliance to the hemoglobin A lC determination standard was 15.7% (physicians 
treating more than 10 patients - 1996).
Physician compliance with the visitation frequency standard also affects the 
remaining standards (lipid profile determination, microalbumin/creatinine clearance 
determination, dilated eye referral, dietitian referral, and nurse educator referral). 
However, these standards are affected to a lesser degree than blood pressure, weight and
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height measurements, foot examinations, and hemoglobin A lC  determinations because 
the ADA’s recommendation is one occurrence per year; allowing the physician to meet 
these standards with only one visit. Therefore, it would seem likely that physicians 
would have better compliance with standards recommended once per year. An 
interesting note with regard to standards recommended once per year was most patients 
were seen at the clinic at least one time in 1995 and in 1996 (1995 - 90.7% o f the main 
clinic’s patients with type 1 diabetes were seen at the clinic at least once; 1996 - 87.7%), 
making it feasible for a higher physician compliance to the ADA Standards 
recommended once per year.
Overall Comparisons
The analysis of the data has shown extremely important results regarding the 
overall care provided to patients with type 1 diabetes by physicians at the participating 
clinics. Results showed that on most occasions physicians were not complying with the 
ADA’s “Standards of Medical Care for Patients with Diabetes Mellitus” when treating 
patients with type 1 diabetes. Low compliance was seen in all sample groups regarding 
the visitation standard and the hemoglobin AlC determination standard, previously 
stated as “key” standards for achieving good control of diabetes. Compliance to the 
lipid profile referral standard and the microalbumin/creatinine clearance referral standard 
were the highest met standards in all sample groups with results ranging from 50-80%. 
However, the overall trend of the data demonstrated that physician compliance to all 
standards was less than optimal for 1995 and 1996.
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The DCCT has conclusively shown that with an intensive treatment program a 
mean hemoglobin A lC of 7.2% can be achieved. (American Diabetes Association: 
Clinical Practice Recommendations, 1997) However, all sample groups’ mean 
hemoglobin AlC values were higher than the recommended 7.2% (Table 14). Overall 
low physician compliance to the standards precluded any trends linking physician 
compliance with lower mean hemoglobin A lC values.
Table 14
Ranking of Sample Groups’ Mean Hemoglobin AlC Values
Rank Sam ple Group Mean 
Memoglobin AIC  
Value
1 1995 Female Physictans - Mam Climc 7 4%
2 1995 AH Physcrans • SateHite Clinics. 1995 Adult Patienta w/ Type i  O abetee - Satellite Ciinics 79%
3 1066 Female Physicians - Main Ciimc, 1995 Physicians Treatino <10 Patients w/ Type 1 Diabetes 8  1%
1995 Adult Patients with Type 1 Diabetes - Mam Clinic 8 3%
5 1995 All Physicians - MamClinic 8 4%
6 1995 Male Physicians - Mam Clinic, 1995 Physicians Treating >10 Patients w/ Type 1 Diatietes 8 5%
7 1996 Adult Patients w/ Type 1 Diabetes-Mam Clihic Physiciens Treating «10 Patients w/ Type 1 Diatietee 8 8%
6 1996 All Physicians - Main Cimic Physicians Treating >10 Patients w/ Type l  Diabetes 8 7%
9 1996 Male Physicians - Main Clinic 8 8%
10 1995 Child Patients w/ Type 1 Diabeles - Mam Clinic 8 9%
11 1996 Child Patients w/ Type 1 Diabetes - Satellite Clinics 9 5%
12 1996 Child Patients w/ Type 1 Diabetes - Mam Ctmic, 1995 AH Physicians - Satellite Clinics 9 7%
13 1996 Adult Patients - Satellite Clinics 9 6%
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Comparison Groups
Main Clinic vs Satellite Clinics
The main clinic’s physicians had a higher compliance to all ADA Standards when 
compared to physicians’ compliance at the satellite clinics. This clear trend may be due 
to the problems associated with rural health care.
Many issues may have attributed to low physician compliance to the ADA 
Standards at the rural based satellite clinics. Two studies, one by Norris, et al. (1996) 
and the other by Vanselow (1990), suggest physicians treating patients in rural areas are 
not prepared for the demands of rural practice, an issue currently being addressed by 
medical schools. This lack of preparation may be an issue relevant to the satellite clinics 
and may have attributed to physicians’ low compliance. However, the researcher for 
this study did not focus on the issues of physician preparedness to care for patients with 
diabetes.
A study performed by Reiber (1996) states persons living in rural areas bypass 
their local health care facilities to seek treatment in urban medical centers; often 
traveling great distances. This Minnesota study found persons living in rural areas 
perceive health care to be better in urban areas than in rural areas. These Minnesota 
rural residents also believe rural medical facilities lack the technology and resources to 
properly care for patients. (Reiber, 1996) The Minnesota study may offer a partial 
explanation of the results found in this study. The researcher discovered evidence that 
some rural were seeking care at the main clinic. The main clinic physician usually 
suggested to the patient to seek care in their own community. However, these patients
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rarely followed through with the physician’s suggestion. Lack of resources may be a 
valid argument explaining low physician compliance to the dietitian and nurse educator 
referral standards. Both satellite clinics do not employ a dietitian and one does not 
employ a nurse educator.
Adult Care vs Child Care - Main Clinic and Satellite Clinics 
In 1995 and 1996 physician compliance to all of the ADA Standards was met at a 
higher percentage for adult patients with type 1 diabetes when compared to compliance 
to the ADA Standard for children with type 1 diabetes. This trend was seen at the main 
clinic and satellite clinics. The only exception was compliance to the nurse educator 
referral standard, which was met at a higher percentage for children with type 1 diabetes. 
This trend, higher physician compliance to the ADA Standards for adult patients, is not 
surprising due to the many problems associated with treating children with type 1 
diabetes. These problems can make physician compliance to the ADA Standards 
difficult. The ADA states that a major issue concerning children and adolescents is that 
of “compliance,” and that no matter how sound the medical regimen, it can only be as 
good as the ability of the family and/or individual to implement it. Behavioral, 
emotional, and psychosocial factors often interfere with the implementation of an 
intensive treatment program. (American Diabetes Association; Clinical Practice 
Recommendations, 1995)
The diagnosis of a child with type 1 diabetes can be devastating to a family and 
necessitates an abrupt life-style change for all family members. Studies indicate that the
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single best predictor of adherence to type 1 diabetes treatment, good metabolic control, 
and prevention of recurring DKA is a reliable, stable family who has undergone 
extensive education. Families who are highly organized and cohesive with open 
communication skills, demonstrate consistent expectations and guidance, and are 
involved in the type 1 diabetes management program are more likely to have children 
with type 1 diabetes in good metabolic control. (Pontious, 1996)
The constant presence of the diabetes care team and strict compliance with ADA 
Standards are essential for the optimal treatment of a child with type 1 diabetes.
Reaching team members quickly at any time of the day is a necessity, providing parents 
and children expert advice, support, and reassurance. (Pontious, 1996) Compliance to 
the ADA Standards for physicians treating children with type 1 diabetes may be difficult. 
However, means must be taken by diabetes care team members to implement strategies 
for children and their parents to comply with standards. Adherence to the ADA 
Standards are integral to the long term health of children with type 1 diabetes.
Physicians Treating More Than 10 Patients with Type 1 Diabetes vs Phvsicians 
Treating Fewer Than 10 Patients with Tvpe 1 Diabetes - Main Clinic 
The researcher stated earlier physicians treating more than 10 patients with type 1 
diabetes might be expected to have higher compliance to the ADA Standards when 
compared to physicians treating fewer than 10 patients with type 1 diabetes. Physicians 
treating more than 10 patients with type 1 diabetes may have a better understanding of 
the ADA Standards and instinctively adhere to standards because of their high rate of
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interaction with patients with diabetes. Physicians treating fewer than 10 patients with 
type 1 diabetes may be more apt to miss certain standards due to their unfamiliarity with 
the ADA Standards. Documented research was not found to support any of these 
expectations; however, analysis of this study’s results showed that physicians treating 
more than 10 patients with type 1 diabetes did in fact have a higher compliance to all 
ADA Standards. The only exception was seen with the nurse educator referral standard. 
A cause for this may be that 97% of the patients treated by physicians treating more than 
10 patients with type 1 diabetes were adults; a higher compliance to the nurse educator 
referral standard was also seen in children with type 1 diabetes when compared to adults 
with type 1 diabetes.
Female Phvsician Care vs. Male Phvsician Care - Main Clinic
Evidence suggests that female physicians may be better suited to optimally treat 
patients with diabetes due to the need for a great deal of interaction between physicians 
and patients during a visit. A study performed by Arnold, Martin, and Parker (1998) 
stated that women physicians seemed better able to show sensitivity and caring toward 
their patients; patients also perceived their female physicians as more caring and 
empathetic. Two studies investigating physician gender differences and communication 
with patients found that female physicians conducted longer visits, made more positive 
statements, asked more questions, smiled and nodded more, talked more, engaged in 
more positive talk, engaged in more partnership building, and gave more information 
during visits. (Hall, Irish, Roter, Ehrlich, & Miller, 1994; Roter, Lipkin, & Korsgaard,
6 6
1991) Another study investigated gender differences in patient-physician communication 
during pediatric visits and had similar findings. Female physicians visits were 29% 
longer, female physicians engaged in more social exchanges, offered more 
encouragement and reassurance, and communicated more with children when compared 
to male physicians. Parents were more satisfied with female physicians, while the 
children stated they were more satisfied with physicians of the same gender. However, 
all children communicated more with female physicians. (Bemsweig, Takayama,
Phibbs, Lewis, & Pantell, 1997) These studies suggest attributes that could greatly 
enhance diabetes care.
The above mentioned studies suggested to the researcher a higher compliance to 
the ADA Standards might be seen in female physicians. However, analysis of the data 
showed male physicians’ and female physicians’ compliance to the ADA Standards was 
similar, with a slightly higher compliance demonstrated by male physicians. This slight 
difference may be due to the fact that all female physicians were grouped in the sample 
group “physicians treating fewer than 10 patients with type 1 diabetes.” The few patients 
female physician treated in this study may have contributed to the male physicians 
having a slightly higher compliance to the ADA Standards. As mentioned earlier, 
treating a small number of patients with diabetes may be a hindrance to compliance with 
the ADA Standards.
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Possible Causes for Low Compliance to the ADA Standards
Patient non-compliance and physicians’ differing interpretations and perceived 
strictness to some of the ADA Standards may have contributed to low physician 
compliance with the ADA Standards at the participating clinics. Physicians and patients 
are recognized as being equally important to complying with the visitation frequency 
standard. However, the remaining ADA Standards (blood pressure, weight and height 
measurements, foot examinations, a lipid profile, hemoglobin AlCs, a microalbumin or 
creatinine clearance, and referrals to an ophthalmologist, dietitian, and nurse educator) 
are solely controlled by physicians. The researcher limited the effects of non-compliant 
patients on the visitation frequency standard by not including the following patients with 
type 1 diabetes: 1) patients named non-compliant by their physician, 2) patients non- 
compliant due to lack of insurance, 3) patients canceling repeated appointments, and 4) 
patients not returning within the time suggested by their physician for an appointment. 
Forty-one patient’s medical charts who have type 1 diabetes were removed from this 
study due to patient compliance problems. Lack of patient insurance for laboratory 
analyses and patients fear of laboratory analyses were cited in some patient charts as to 
the reason why certain labs were not performed (lipid profile, hemoglobin A 1C, and 
microalbumin/creatinine clearance). However, this study gave credit to the physician for 
the suggestion that the patient needed certain labs performed in addition to actual 
laboratory analysis data This study has reported a large number of medical charts not 
included in the study due to non-compliance issues. Steps need to be taken to try to 
rectify this problem of patient non-compliance.
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The design and initiation of a continuous and comprehensive educational 
program targeted at patients with diabetes to promote behavioral changes associated with 
optimal diabetes self-management may be beneficial in patient non-compliance 
problems. This educational program should be implemented by the physicians caring for 
patients with diabetes and the rest o f the diabetes care team.
The initiation of this program should start with a needs assessment of all patients 
with diabetes. This needs assessment should address personal life-style histories 
associated with each patient Key issues are:
characteristics that influence behavior of the patient 
behavioral goals of the patient
patient’s strengths and weaknesses to past behavioral changes 
patient’s knowledge of diabetes 
barriers that may affect change
patient’s attitudes toward diabetes and current diabetes care
patient’s attitude toward her/his physician
patient’s social support system including family and friends
attitude o f patient’s employer to her/his diabetes
patient’s attitude toward the clinic and other team members
Behavioral goals should be established by the diabetes care team for the patient 
based upon the patient’s and diabetes care team’s goals. Measurable objectives should 
be developed by the diabetes care team to evaluate patient progress. The design of the
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educational program should include behavioral change theories. (M cKenzie & Smeltzer, 
1997)
One o f  the strongest theories that would help aid patients' and physicians’
|nce with ADA Standards is the Health B elief M odel (HBM). The Health B elief 
Jtates that three factors need to be present for a health related action to take place, 
1) the existence o f a health concern, 2) the belief that one is susceptible to a serious 
health concern, 3) the belief if  action is taken, the risk o f  the health concern will be 
reduced. The HBM is extremely relevant to patients with diabetes and physicians 
treating patients with diabetes. For example, long term  com plications associated with 
diabetes are the patient’s and physician’s health concern. The patient and physician must 
believe the patient is susceptible to long-term complications. I f  the patient and physician 
comply w ith an intensive treatment program they must believe the patient will reduce the 
threat and risk o f  long term complications.
The Transtheoretical M odel or Stages o f  Change consists o f  five steps that can 
help the patient prepare for change. The five steps include 1) Precontemplation - not 
thinking about change in the next six months, 2) Contemplation - seriously thinking 
about change in the next six months, 3) Preparation - actively planning change, 4) Action 
- making changes, 5) M aintenance - taking steps to sustain change and resist relapse.
This model provides the diabetes care team with an understanding that each patient 
accepts change at a different pace. Change is not a smooth process and very rarely do 
people progress through the stages linearly. ("Just do it’’isn’t enough: change comes in 
stages, 1996) Patients with diabetes vrill most likely be in different stages o f  change with
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each treatment goal. Interventions need to be targeted to where patients are in terms of 
stages of change for each treatment goal.
The Stimulus Response Theory states the use of positive or negative 
reinforcements and punishments can help increase or decrease the targeted behavior 
change. Physicians could use acceptable hemoglobin AlC values and the new behaviors 
learned by the patient to accomplish acceptable values as a reinforcement to help the 
patient and physician comply with ADA Standards. The use of this behavior change may 
help the patient want to return for visits and help the physician become more accountable 
for their patient’s well-being.
The wording o f the ADA’s visitation standard leaves room for varying 
interpretations. In addition, four physicians at the participating clinic suggested to the 
researcher that the 1995/1996 visitation frequency and hemoglobin A lC determination 
standards were too strict. Physicians’ differing interpretations and perceived strictness of 
the ADA Standards may have attributed to low physician compliance to the ADA 
Standards.
The 1997 ADA recommendation for visitation frequency is:
Insulin-treated patients should generally be seen at least quarterly until 
achievement of all treatment goals. Thereafter, the frequency of visits may be 
decreased as long as the patient continues to achieve all treatment goals, (p. S8)
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This statement is compared to the 1995/1996 ADA recommendation for visitation 
frequency which states:
Regular visits should be scheduled for insulin-treated patients at least quarterly 
depending on achievement of treatment goals, (p. 11)
The differences between these two statements are very subtle. Both 
recommendations suggest less frequent visits may be assumed when the patient achieves 
treatment goals. The addition of the last sentence in the 1997 ADA recommendation for 
visitation merely reiterates less frequent visits may be assumed as long as the patient 
achieves treatment goals. The statement “achievement o f treatment goals” allows for 
varying interpretations with regard to the frequency of visits. However, the ADA does 
not state what specific treatment goals need to be met to validate “less frequent visits.” 
Furthermore, the ADA does not recommend frequency of visits if  treatment goals are 
achieved by the patient.
The 1997 ADA recommendation for hemoglobin A lC determinations states:
A hemoglobin AlC measurement should be performed approximately every three 
months to determine whether a patient’s metabolic control has remained 
continuously within the target range ... For any individual patient, the frequency 
of hemoglobin A lC  testing should be dependent on the treatment regimen 
employed and on the judgement of the clinician. Expert opinion recommends 
hemoglobin AlC testing at least one or two times a year in patients with a history 
of stable glycémie control and quarterly assessments in patients whose therapy 
has changed or who are in poor control, (p. S8)
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This statement is compared to the 1995/1996 ADA recommendation for 
hemoglobin A lC determinations which states:
A hemoglobin AlC determination should be performed at least quarterly in all 
insulin treated patients, (p. 11)
The 1997 ADA recommendation for hemoglobin AlCs is clearly different from 
the 1995/1996 recommendation. The recommendation for the 1997 hemoglobin AlC 
standard suggests a more lenient approach to the frequency of hemoglobin AlC 
determinations, supporting the physicians’ claim that the 1995/1996 hemoglobin A lC 
determination standard was too strict.
As seen above, the visitation frequency standard allows for varying 
interpretations. Given the impact of the visitation standard on all other standards, 
differing interpretations may have attributed to low physician compliance to all ADA 
Standards. Physicians’ perceived strictness of hemoglobin A lC determinations may 
have also affected the results for this standard. However, this study assumed a very strict 
interpretation of the 1995/1996 ADA Standards for two specific reasons, 1) the ADA 
does not offer recommendations for visitation frequency if treatment goals are met by the 
patient, and 2) the ADA does not state specific treatment goals that must be met for a 
more lenient approach to be warranted.
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Recommendations
Results of this study indicate compliance with the ADA Standards could be 
greatly improved by physicians at the participating clinics. No attempt has been made to 
generalize any of this study’s findings to other clinics and hospitals. However, review of 
the literature has shown a lack of information documenting the quality of care received 
by patients with diabetes based upon the ADA’s “Standards of Medical Care for Patients 
with Diabetes Mellitus.” This lack of information, coupled with this study ’s findings of 
low physician compliance with the ADA Standards, supports the need for 
reconunendations for improving compliance with ADA Standards. These 
recommendations are grouped in two categories: 1) the administration of health care 
facilities, and 2) physicians and other diabetes care team members treating patients with 
diabetes The following recommendations are suggested:
1. Specific recommendations for the administration of health care facilities:
Support compliance with the ADA’s “Standards of Medical Care for 
Patients with Diabetes Mellitus.”
Support an alliance in institutions with an established affiliation between 
large (urban based) and small (rural based) health care facilities. A strong 
alliance may ensure provision of allied health care professionals and the 
use of technology and resources that may be absent in smaller (rural 
based) health care facilities. If a lack of affiliation exists, small (rural 
based) health care facilities need to address the concept of regional 
support. Examples for affiliated institutions may include the concept of
»
*
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job-sharing; unaffiliated health care facilities should cooperate with 
regional health care facilities that can provide needed resources.
* Provide ongoing support, information, and education to rural based health 
care facilities and physicians treating few patients with diabetes in efforts 
to equal the care provided in urban based health care facilities and by 
physicians treating many patients with diabetes. Ongoing support, 
information, and education should include:
a yearly overview of the ADA Standards 
in-service training
the use of e-mail and the Internet to find, forward, and discuss 
relevant issues and information 
Unaffiliated rural health care facilities need to address the concept of 
regional education and training programs.
* Regularly and routinely assess physician compliance to the ADA’s 
“Standards of Medical Care for Patients with Diabetes Mellitus.”
2. Specific recommendations for physicians and other diabetes care team members:
* Ensure the coding system correctly classifies patients with type 1 and type 
2 diabetes.
* Define and agree on the interpretation of the ADA Standards, including a 
definition of “treatment goals” and a recommendation for visitation 
frequency if patients are achieving treatment goals.
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Support compliance with the ADA’s “Standards of Medical Care for 
Patients with Diabetes Mellitus”.
Educate patients with diabetes regarding the existence and importance of 
the ADA Standards during a regular diabetic visit; thoroughly discussing 
each standard. Suggestions to aid patient education 1) give all patients 
with diabetes and/or family members a pamphlet explaining the ADA 
Standards, and 2) place a poster detailing the ADA Standards for patients 
with type 1 and type 2 diabetes in all examination rooms.
Design, implement, and evaluate a continuous and comprehensive 
educational program using behavioral change theories targeting patients 
with diabetes patients to help promote behavioral changes associated with 
optimal diabetes self-management. Specific behavioral change theories 
used in the educational program should include the Health Belief Model, 
Transtheoretical Model, and the Stimulus Response Theory,
Develop and implement a means of quickly assessing compliance to ADA 
Standards. Examples of flow-sheets (see Figures 2 and 3) to track 
compliance with the ADA Standards for adults and children are provided
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D iabetes Visits 
(Quaiterly)
D ate j ! I
1
Blood P ressure 
M easurem ent D ate j I I
(During All OiabctBS Visits) Value
W eight M easurem ent Date
1
(During All Diabetes Visits) Value Î  i  I  i
Foot Examination Date
(During AH Diatietes Visits) Perform ed j 1 . . . . . . . . 1. . . . . . .
Funduscopy D ate 1 ' 1 .................1. . . . ..(During All Dfabetes Visits) Perform ed .. I I 1
LABS
j Hemoglobin A lC  
j  Analysis (Quarterly)
Date
Value
_________
1
Lipid Profile 
j (Once per Year)
Date I
Total Choi
LDL/ HDL
i
! I
TG
j  Microalbumin 
1 (Once per Year)
Date 1 I 
1
Value
________  . .  . - - .................. . . ....................................1 .
REFERRALS
Dilated Eye Referral
1
D ate 1
I
(Once per Year) D ate of 1 
Exam 1 1 1 f  1
Nurse Educator Referral 
(O nce per Year)
. . . . .
■
D ate !  !
D ate of 
Exam .. !  1
Figure 2. Flow-sheet designed to track the occurrence of ADA Standards for adults with 
diabetes.
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D iabetes Visits 
(Quarterly)
Date ! ■
!
Blood P ressure 
M easurem ent
(During AH Diabetes Visits)
Date
Value 1 J
Weigtit M easurem ent
(During All Diabetes Visits)
Date
Value j 1
Height M easurem ent 
(Ounng Alt Diabetes Visits)
Date
■■■ ' ............  r ..... -
Value
.................. J . , _ .  . . . . .
Foot Examination 
(During Alt Diebeles Visits)
Date 1 1 1 1
Perform ed
Funduscopy 
(During AH Diabetes Visits)
Date
Perform ed
.. _ _ . . . L. . ... ._ . . .  .  [................... 1 .....................
Sexual Maturation
(PeridodicaHy)
.
Date
Perform ed
LABS
Hemoglobin A lC  
Analysis (Quarterly)
Date
1 j
Value Î.
Lipid Profile 
(O nce per Year)
Date 1 1 I
Total Choi . ................ !.. !
LDL/ HDL I
!
Microalbumin 
(O nce per Year)
Date
Value 1
REFERRALS
1 Dilated Eye Referral
\ I
Date j
(Once per Year) Date of I
Exam  1 1
!
i Dietitian Referral D ate 1
■ ■  y . . . . . . . . .
(Once per Year)
1
D ate of 
Exam  1
! '
Nurse Educator Referral
■
Date
1 (O nce per Year) Date of 
Exam
Figure 3. Flow-sheet designed to track the occurrence of ADA Standards for children 
with diabetes.
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APPENDIX A 
1995 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic
ADA Standard
«
of
Charts
ADA recommendation 
for Standard (• of 
oocunencea per year)
Mode
Percentage
at
Mode
Percentage at 
occurrences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrencee 
>4
Percentage 
not meeting ADA 
recommendation
Peicentage 
meeting or exceeding 
AOA recommendeUon
Visitation Standard t07 4 1 25 2 9 3 25 2 150 9 3 10 3 308 580 41 1
Blood Pressure 
Measurement 
Standard
107 4 1 29 0 131 290 140 9 3 7 5 27 1 654 346
WeoW
Measurement
Standard
107 4 1 308 12 1 30.8 131 13 1 112 196 6 92 30 6
Hergtrt
Measurement
Standard
16 4 0 37 5 37 5 31 3 313 0 0 0 0 0 0 1000 0 0
Foot Examination 
Standard 107 4 0 561 561 29 9 7 5 2 8 19 19 963 37
Hemoglobin AlC 
Déterminai ion 
Standard
107 4 1 37 4 16 8 374 24 3 13 1 47 3 7 91 6 8 4
Lipid Profile 
Standard
91 1 1 42 9 33 0 429 n/a n/a n/a n/a 33 0 67 0
Microaltiumin / 
Creatinine 
Clearance 
Standard
91 1 0 464 484 34 1 n/a n/a n/a n/a 48 4 516
Dilated Eye Referral 
Standard
94 1 0 543 54 3 36.2 n/a n/a n/a n/a 54 3 45 7
Dietitian Referral 
Standard
16 1 0 56 3 563 188 n/a n/a n/a n/a 563 4 3 8
Nurse Educator 
Referral Standard
107 1 0 650 850 6 5 n/a n/a n/a n/a 65 0 150
00w
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APPENDIX B 
1996 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic
1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic
AOA Standard
»
of
Charts
AOA necotmnendallon 
for Standard (# of 
occurrences par year)
Mode
ffercentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at Percentage at 
2 3 
occurrences | occurrencee
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meetino or exceeding 
ADA recommendttion
Visitation Standard
Blood Pressure 
Measurement 
Standard
122
122
4
4
t
1
24 6
27 9
12 3 
16 4
24 6  
279
148
156
115 5 7 31 1 631 369
10 7 2 5 27 0 70.5 295
Weigtrt
Measurement
Standard
Height
Measurement
Standard
122
20
4 1 31 1 15 6 311 
350
156
150
9 0 41 24 6 713 28 7
4 0 50 0 5 0 0 0 0 0 0 0 0 100 0 0 0
Foot Examinatton 
Standard 122
4 1 41 0 
31 1
393 410 12 3 4 1 16 16 967 3 3
HemogtoWn A1C 
Determination 
Standard
122 4 1 2 13 31 1 24 6 9 8 8.2 4 9 869 131
Lipid Profile 
Standard 101
1 1 46 5 29 7 485 nfa n/a n/a n/e 29 7 70.3
“Hicroalbumin / 
Creatinine 
Clearance 
Standard
103 1 1 44 7 369
551
447 n/a n/a n/a n/a 369 63.1
Dilated Eye Referral 
Standard
Dietitian Referral 
Standard
Nurse Educator 
Referral Standard
107 1 0 551 32 7 n/a n/a n/a n/a 551 44 9
19 1 0 263 26 3 15.8 n/a n/a n/a n/a 263 73 7
122 1 0 63 9 63 9 148 n/a n/a n/a n/a 6 39 361
00
KJi
86
APPENDIX C 
1995 Physician Compliance to ADA Standards 
for Patients with Type I Diabetes 
Main Clinic - Adults with Type I Diabetes
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic - Adults with Type I Diabetes
ADA Standard
«
of
Ctiarts
ADA ifcofflnwndauan 
for Standard (# (d 
occurrences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
> 4
Percentage 
not meeting AIDA 
recommendation
Peroentage 
meeting or exceading 
ADA recommandation
Viaitalton Standard
Stood Pressure 
Measurement 
Standard
WeigW
Measurement
Standard
Heigtrt
Measurement
Standard
91
91
4 1 231 
25 3
8 8
121
231 
25 3
165
13.2
77
9 9
9 9 341 56 0 44 0
4
4
1
1
8.6 308 604 396
91 29 7 12 1 297 110 132 12 1 22 0 65 9 341
n/a nfa n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Fool Examination 
Standard
HemoQtobin AtC 
Determination 
Standard
Lipid Profile 
Standard
91
91
4 0 495 49 5 341 8.8 3 3 22 2 2 95.6 4 4
4 1 363 18 7 363 20 9 143 4 9 3.9 901
330
9 9  
67 091 1 1 42 9 330 429 n/a n/a n/a n/a
Microalbumin/
Creatinine
Clearance
Standard
86 1 0 477 47 7 3 49 n/a n/a n/a n/a 47 7 523
Dilated Eye Referral 
Standard 86
n/a
1 0 557 557 35 2 n/a n/a n/a n/a 557 44 3
Dietlten Referral 
Standard
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Nurse Educator 
Retenal Standard 91
1 0 890 890 77 rVa n/a n/a n/a 89 0 11 0
00
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APPENDIX D 
1996 Physician Compliance to ADA Standards 
for Patients with Type I Diabetes 
Main Clinic - Adults with Type I Diabetes
1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic - Adults with Type I Diabetes
AOA Standafd
n
of
ctiarts
ADA recommendation 
for Standard (4 of 
occurrences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at
3
occunencee
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting AOA 
recommendation
Percentege 
meeting or exceeding 
AOA recommendation
Visitation Standard 104 4 1 260 10 6 260 115 125 4 8 346 6 0 6 394
Blood Pressure 
Measurement 
Standard
104 4 1 250 12 5 250 15 4 125 2 9 317 654 346
Weight
Measurement
Standard
104 4 1 296 13.5 298 144 9 6 3 8 288 67 3 32 7
Height
Measurement
Standard
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Fort Examination 
Standafd 104 4 1 44 2 33 7 433 135 4 8 19 19 962 3 8
Hemoglobin A1C 
(Détermination 
Standard
104 4 1 29 8 22 1 29 8 24 0 9 6 8 7 5.8 8 56 144
Lipid Profile 
Standard 101
1 1 48 5 297 48 5 n/a n/a n/a n/a 29 7 70 3
Mlcroattiumin T  
Creatinine 99 1 1 455 35 4 455 n/a n/a n/a n/a 354 64 6
Standard
Dilated Eye Referral 
Standard 99
1 0 53 5 535 33 3 n/a n/p n/a n/a 5 35 465
Dietitian Referral 
Standard 1
1 7 1000 0 0 0 0 n/a n/a n/a n/a 0 0 100.0
Nurse Educator 
Referral Standard
104 1 0 683 68 3 135 n/a n/a n/a n/a 6 83 317
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APPENDIX E 
1995 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Children with Type I Diabetes
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic - Children with Type I Diabetes
ADA Standard
*
of
Charte
AOA lecommendatton 
for Standard (ft of 
occurrences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at
1
occurrence
Percentage at
2
occurrences
Percentage at
3
occurrences
Percentage at 
4
occunences
Peroentageof 
occurrences 
> 4
Percentage 
not meeting ADA 
recommendation
Percsntags 
meeting or Mcesding 
/VOA rscdmmendetlon
Visitation Standard
Btood Pressure 
Measurement 
Standard
Weight
Measurement
Standard
Height
Measurement
Standard
16 4 1 37 5 125 
18 8
37.5 6 3 188 125
0 0
12 5 73 3 26 7
16 4 1 500 500 188 6 3 6 3 9 38 6 3
16
16
4
4
1
0
37 5 125 37 5 
3 13
250  
31 3
12 5 
0 0
6 3
0 0
6 3
0 0
87 5 
1000
125
37 5 37 5 0 0
Fort Examinatior 
Standard
HemoototHO A te  
Determination 
Standard
Lipid Profite 
Standard
16 4 0
1 and 2 
n/a
938  
43 8 
n/a
6 3 0 0 0 0 0 0 0 0 0 0 1000
1000
0 0
0 016
n/a
4
n/a
6 3 438 438 6 3 0 0 0 0
n/a n/a n/a n/a n/a n/a n/a n/a
Microâtbumin 1 
Creatinine 
Oearance 
Standard
5 1 0 600 60 0 20 0 n/a n/a n/a n/a 60 0 4 0 0
Dilated Eye Referral 
Standard 6
1 1 500 33 3 900 n/a n/a n/a n/a 333 667
Dietitian Referral 
Standard 16
1 0 563
62 5
56 3 
625
186 n/a n/a n/a n/a 563 4 3 8
Nurse Educator 
Referral Standard
16 1 0 188 n/a n/a n/a n/a 62 5 375
VO
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APPENDIX F 
1996 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Children with Type I Diabetes
1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic • Children with Type I Diabetes
ADA Standard
Visitation Standard
Btood Pressure 
Measurement 
Standard
M
of
Charts ___
18
ADA lecomrsendstton 
for Standard (ff of 
occurrences par yeah
4
Mode
2
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
AOA recommendation
333 222 16 7 333 5 6 11 1 11 1 778 22.2
18 4 1
1
44 4 389 444 167 0 0 0 0 0 0 100 0 0 0
Weight
Measurement
Standard
16 4
4
389 27 8 389 222 
16 7
5 6
0 0
5 6
0 0
0 0
0 0
944 5 6
Height
Measurement
Standard
Foot Examination 
Standard
Hemoglobin A1C 
Determination 
Standard
Lipid Profile 
Standard
18 0 500 500 33 3 1000 0 0
16
10
4 0 722
369
n/a
72 2 222 5 6 0 0 0 0 0 0 1000 0 0
4 1
n/a
16 7 389 27 8 11 1 5 6 0 0 9 44 5 6
Ufa n/a n/a n/a n/a n/a n/a n/a n/a n/a
Micfoalbumin / 
Creatinine 
Clearance 
Standard
4 1 0 750 75 0 250
250
n/a n/a n/a n/a 750 250
Dilated Eye Referral 
Standard
8 1 0 750 750 n/a n/a n/a n/a 7 5 0 25 0
Dietitian Referral 
Standard 18
1 0 27 8 27 8 16 7 n/a n/a n/a n/a 27 8 72 2
Nurse Educator 
Referral Standard
10 1 0 389 389 222 n/a n/a n/a n/a 389 61 1
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APPENDIX G 
1995 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Female Physicians
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic - Female Physicians
ADA Standard
«
of
Cltarls
ADA recomnwndation 
for Stands id (* of 
oocurrancas par year)
Mode
Percentage
at
Mode
Percentage at 
0
occunences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at 
3
occunences
Peroentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting Of exceeding 
ADA recommendation
Visitation Standard 17 A Oand 1 23 5 23 5 23 5 17 6 118 0 0 235 76.5 235
Blood Pleasure 
Measurement 
Standard
17 4 1
Oand 1
412
29 4
23 5 41 2 
29.4
5 9 5 9 0 0 235 765 235
Weigtit
Measurement
Standard
17 4 294 118 5 9 0 0 23 5 76.5 235
Hetghl
Measurement
Standard
6 4 1 667 16 7 667 16 7 0 0 0 0 0.0 1000 0 0
Foot Examination 
Standard 17 4 0
62 4 62 4 
11 6 
545
118 5 9 0 0 0 0 0.0 1000  
94 1
DO
5 9
Hemoglotiin A1C 
Determination 
Standard
17 4 1 52 9 52 9 294 0 0
n/a
0 0 5 9
Lipid Profile 
Standard 11 1
0 54 5 364 n/a n/a n/a 545 45 5
Microatbumin !  
Creatinine 
Clearance 
Standard
12 1 0 583 583 25 0 n/a n/a n/a n/a 583 41.7
Dilated Eye Reterral 
Standard 13
1 0 692 692 308 n/a n/a n/a n/a 69 2 308
Dietitian Referral 
Standard
6 1 0 333 333 16 7 n/a n/a n/a n/a 333 667
Nurse Educator 
Referral Standard
17 1 0 52 9 52 8 176 n/a n/a n/a n/a 529 47 1
VO
U»
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APPENDIX H 
1S96 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Female Physicians
1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Ciinic - Femaie Physicians
ADA Standard
#
of
Charts
ADA recommendation 
for Standard of 
occuirencee per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at
1
occurrence
Percentage at
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
> 4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
ADA lecommendanon
Visitation Standard 20 4 1 250 150 250 100 100 100 300 60 0 40 0
Blood Pressure 
Measurement 
Standard
20 ' 360 26 0 350 100 5 0 5 0 200 750 250
Weight
Measurement
Standard
20 4 1 300 260 30 0 100 150 0 0 200 800 2 0 0
Height
Measurement
Standard
7 4 0 57 1 57 1 286 14 3 0 0 0 0 0 0 1000 0 0
Foot Examination 
Standafd 20 4 0 GOO 600 250 100 0 0 5 0 0 0 9 5 0 5 0
Hemoglotiin A1C 
Determination 
Standard
20 4 1 450 150 45 0 300 5 0 0 0 5 0 9 5 0 5 0
Lipid Profile 
Standard 12
1 1 563 250 563 n/a n/a n/a n/a 250 7 5 0
Microaltjumln 1 
Creatinine 
Clearance
13 1 0 46 2 462 365 n/a n/a n/a n/a 462 5 38
Dilated Eye Referrel 
Standard
15 1 0 53 3 53 3 33 3 n/a n/a n/a n/a 5 3 3 46 7
Dietitian Referral 
Standard 7
1 2 28 6 266 14 3 n/a n/a n/a n/a 286 714
Nurse Educator 
Referral Standard
20 1 0 500 50 0 200 n/a n/a n/a n/a 50.0 5 00
>̂1
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APPENDIX I
1995 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Male Physicians
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic • Male Physicians
AOA Standard
«
of
Charts
ADA recommend Aon 
for Standard (A of 
occurrences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
ADA recommendation
Visitation Standard 90 4 1 25 6 67 256 144 8 9 122 322 556 444
367
Bood Pressure 
Measurement 
Standard
90 4 1 267 11 1 26 7 15 6 100 8 9 267 833
Weight
Measurement
Standard
90 4 1 300 8 9 300 133 144 13 3 189 67 8 322
Height
Measurement 10 
Standard
4 0 500 500 100 400 0 0 0 0 0 0 100 0 0 0
Fix* Examination
Standard ^
4 0 51 1 51 1 33 3
34 4
7 8
23 3
3 3  
15 6
2 2
5 6
22  
3 3
956  
91 1
4 4
8 9
HemogtotMn A1C 
Determination 90 
Standard
4 1 344 17 8
Lipid Profile ™ 
Standard
1 1 43 8 309 438 n/a n/a 31 3 68 8
Microalbumin / 
Creatinine 
Clearance 
Standard
1
1
0 46 8 46 8 35 4 n/a n/a n/a n/a 468 53 2
Dilated Eye Referral 
Standard
Detifian Referral 
Standard
81 0 51 9 51 9 370 n/a n/a n/a n/a 51 9 481
10 1
1
0 700 700 200 n/a n/a n/a n/a 700 3 00
Nurse Educator 
Referral Standard
”
0 91 1 01 1 4 4 n/a n/a n/a n/a 91 1 8 9
100
APPENDIX J
1996 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Male Physicians
1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic - Male Physicians
ADA Standard 
Visitation Standard
#
of
Charts
AOA lecommendarion 
tor Standard (# of 
occurrences per veai)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Peroentage at j Percentage ait 
2 3 
occurrences ! occurrences
Percentage at 
4
occurrences
Percentage ot 
occurrences 
> 4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or enceeding 
AOA recommendation
102 4 1 245 11 0 24 5 15 7 11 8 4 9 314 637 363
Blood Pressure 
Measurernent 
Standard
Weight
Measurement
Standard
Height
Measurement
Standard
Foot Examination 
Standafd
102 4 1
1
26 5 147 26 5 16 7 118
.
2 0 284 666 304
102
13
102
4
4
314 13 7 314 16 7 78 4 9 255 69.6 304
0 46 2 462 385 15 4 0 0 0 0 0 0 1000 0 0
4 1 44 1 353 44 1 127 4 9 1 0 2 0 97 1 2 9
Hemoglobin A 1C 
Determination 
Standard
Lipid Profile 
Standard
102
89
4 1 28 4 22 5 20 4 23 5 10 8 9 8 4 9 05 3 14 7
1 1 46 1 315 461 n/a n/a n/a n/a 31 5 6 8 5
Mtcroalbumin / 
Creatinine 
Clearance 
____ g a p W ____
Dilated Eye Retenal 
Standard
90 1 1
0
45 6 35.6 45 6 n/a n/a n/a n/a 356 64 4
92 1 554 554 326 n/a n/a nfa n/a 554 44 6
Dietitian Referral 
Standard
12 1 Oand 2 25 0 25 0 16 7 n/a n/a n/a n/a 250 75 0
Nurse Educator 
Referral Standard
102 1 0 667 667 147 n/a n/a n/a n/a 65 7 34 3
102
APPENDIX K 
1995 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Physicians Treating >10 Patients with Type I Diabetes
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Ciinic - Physicians Treating >10 Patients with Type I Diabetes
ADA Standard
n
of
Charts
AOA recommendation 
for Standard (# of 
occurrenoM per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence 
25 7
Percentage at
2
occurrences 
14 9
Percentage at 
3
occurrences
81
Percentage at 
4
occurrences
9 5
Percentage of 
occurrences 
> 4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
ADA recommendation
Visitation Standard
Blood Pressure 
Measuremerrt 
Standard
74 4 1 25 7 6 8 351 554 44 6
74 4 1 27 0 108 270 122 9 5 9 5 31.1 59 5 405
Weight
Measurement
Standard
74 4 1 31 1 9 5 31 1 10 8 13 5 13 5 216 649 351
Height
Measurement
Standard
1 4 1 1000 0 0 1000 0 0 0 0 0 0 0 0 1000 0 0
Foot Examination 
Standard
74 4 0 500 500 35.1 9 5 27 14 14 97 3 2 7
Hemoglotiin A1C 
Determination 
Standard
74 4 1 351 18.9 351 216 16 2 5 4 27 91 9 81
Lipid Profile 
Standard
73 1 1 425 301  
47 1
42.5
357
iVa
n/a
n/a
n/a
n/a
n/a
n/a
n/a
301  
47 1
6 99  
52 9
Micfoalbuinin / 
Creatinine 
Clearartce
___ Standard.____
dilated Eye Referral 
Standard
70 1 0 47 1
70 1
1
0 54 3 543 35 7 n/a n/a n/a n/a 5 4 3 45 7
Dietitian Referral 
Standard 1
0 100 0 100 0 0 0 n/a n/a n/a n/a 1000 0 0
Nurse Educator 
Referral Standard
74 1 0 91 9 919 41 n/a n/a n/a n/a 9 19 61
. .
O
W
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APPENDIX L 
1996 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Physicians Treating >10 Patients with Type I Diabetes
1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic • Physicians Treating >10 Patients with Type I Diabetes
ADA Standard
«
of
Charts
ADA rtcommendstton 
for Standard (# ci 
eccurrances per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at
2
occurrence*
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentsg* 
meeting or exceeding 
AOA recemmendstlon
Visitation Sandafd 03 4 1 25 3 12 0 25 3 120 108 3 6 361 602 39 8
Stood Pressure 
Measurement 
Standard
83 4 1 25 3 13 3 25 3 15 7 10 8 2 4 325 651 349
WelghI
Measurement
Standard
83 4 1 301 133 301 14 5 8 4 4 8 28 9 6 6 3 33 7
Height
Measurement
Standard
3 4 0 1000 1000 0 0 0 0 0 0 0 0 0 0 1000 0 0
Foot Examination 
Standard
83 4 1 434 343 4 434 133 6 0 12 2 4 964 3 6
Hemogtobin A1C 
Determination 
Standard
83 4 1 28 9 22 9 28 9 25 3 7 2 9 6 6 0 843 157
Lipid Profile 
Standard 80
1 1 46 3 31 3 463 n/a n/a n/a n/a 31 3 688
Mtcroalbumin F  
Creatinine 
Clearance 
Standard
77 1 1 49 4 162 494 n/a n/a n/a n/a 31.2 68 8
Dilated Eye Referral 
Standard
77 1 0 51 9 51 9 351 n/a n/a n/a n/a 519 461
Detitian Referral 
Standard
1 1 7 1000 0 0 0,0 n/a n/a n/a n/a 0 0 1000
Nurse Educator 
Referral Standard
S3 1 0 63 9 639 16 9 n/a n/a n/a n/a 6 3 9 361
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APPENDIX fA 
1995 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Physicians Treating <10 Patients with Type I Diabetes
1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Main Clinic - Physicians Treating <10 Patients with Type I Diabetes
ADA Standard
#
of
Ctiarts
ADA recommendenan 
for Standard of 
occurrences per year)
Mode
Percentage
at
Mode
Ffercentage at
0
occurrences
Percentage at 
1
occurrence
Percentage at
2
occurrences
Percentage at
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
AOA recommendation
Wailalion Standard
Btood Pressure 
Measurement 
Standard
33 4 1 25 7 15 2 24 2 15 2 121 121 0 2
182
667 333
33 4 1 333 16 2 333 182 91 3 0 78 8 21 2
Weight
Measurement
Standard
33 4 1 303 16 2 303 18 2 121 61 15 2 78 8 212
Herght
Measurement
Standard
15 4
4
0 400 400
697
26 7 
18 2
333
3 0
0 0
3 0
0 0
3 0
0 0
3 0
100 0 
9 3 9
0 0
6 1Foot ©ramtnalion 
Standard 33
0 697
HemogtotNn A1C 
Determination 
Standard
33 4 1 424 121 42 4 30.3 61 3 0 61 90.9 91
Liptd Profile 
Standard
Mlcroaltjurninj
Creetrnine
Clearance
Standard
16 1 0 44 4 444 44 4 n/a n/a n/a n/e 44 4 5 5 6
21 1 0 524 52 4 28 6 n/a n/a n/a n/a 52 4 47 6
Dilated Eye Referral 
SlarKferd
24 1 0 54 2 54 2 375 n/a n/a nfa n/a 542 46 8
467Dietitian Referral 
Standard
15 1 0 533 533 200 n/a n/a n/a n/a 5 3 3
Nurse Educator 
Referral Standard
33 1 0 697 697 121 n/a n/a n/a rVa 697 30 3
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1996 Physician Compliance to ADA Standards for 
Patients with Type I Diabetes 
Main Clinic - Physicians Treating <10 Patients with Type I Diabetes
1996 Physician Compiiance to ADA Standards for Patients with Type I Diabetes 
Main Clinic • Physicians Treating <10 Patients with Type I Diabetes
ADA Standard
visitation Standard
Btood Pressure 
Measurement 
Standard
n
of
Charts
ADA recommandation 
for Standard (A of 
occurrences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occunence
Percentage at 
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
> 4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
ADA recommendation
39 4 1 23.1 128
231
231 20 5 12 8 103 205 692 30 8
39 4 1 333
333
333 15 4 10 3 2 6 154 821 17 9
Weight
Measurement
Standard
39 4
4
1
Oand 1
205 333 17 9 10 3 2 6 154 821 17,9
Heigtit
Measurement
Standard
17 41 2 41 2 41 2 17 6 0 0 0 0 0 0 1000 0 0
Foot Examination 
Standard 39 4
0 51 3 
35 9
513
179
35 9 
35 9
10 3 
231
0 0
154
2 6 0 0 97 4 2 6
Hemoglobin A1C 
Determination 
Standard
39 4 1 51 2 6 923 77
LipkJ Profile 
Standard 21 1
1 57 1 190 57 1 rVa n/a n/a n/a 190 810
Microalt>umin / 
Creatinine 
Clea ranee 
Standard
26
30
1 0 538 53 8 308 n/a n/a
n/a
n/a n/a 53 8 46 2
Dilated Eye Referral 
Standard
1 0 633 63 3 26 7 
176
n/a n/a n/a 633 367
Dietitian Referral 
Standard
17 1 Oand 2 23 5 235 n/a n/a n/a n/a 23 5 765
Nurse Educator 
Referral Standard 39
1 0 61 5 61 5 128 n/a n/a n/a n/a 615 38 5
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1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Satellite Clinics
AOA Standdfd
tf
of
Ctrarts
AOA recommendation 
for Standard W of 
occunences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
267
Percentage at 
1
occurrence 
26 7
Percentage at
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting AOA 
recommendation
Percentage 
meeting or eirceeding 
ADA recommendation
Vraitation Standard 15 4 Oand 1 26 7 0 0 2 0 0 6 7 200 733 26.7
Btood Pressure 
Measurement 
Standard
15 4 0 46 7 46 7 26 7 6 7 0 0 0 0 200 80 0 200
WetgM
Measurement
Standard
15 4 0
0
667
1000
667 2 00 0 0 0 0 13 3 0 0 86.7 13 3
HeigW
Measurement
Standard
4 4 1000 0 0 0 0 0 0 0 0 0 0 1000 0 0
Foot Examination 
Standard
Hemoglobin A1C 
Determination 
Standard
Lipid Profile 
Standard
15 4 0
0
0
0
93 3 
73 3
933  
73 3
6 7 0 0 0 0 0 0 0 0 1000 0 0
15
11
4
1
300 6 7 0 0 0 0 0 0 1O0O 0 0
6 3 6  
100 0
63 6 27.3 n/a n/a n/a n/a 6 36 36.4
Microalbumin / 
Creatinine 
Clearance 
Standard
12 1 1000 0 0 n/a n/a n/a n/a 1000 0 0
Dilated Eye Referral 
Staridard 12
1 0 83 3 833 16 7 
0 0
n/a
n/a
n/a
n/a
n/a n/a 83 3 
1000
16 7 
0 0Diet Kan Referral 
Standard 4
15
1 0 1000 1000 n/a n/a
Nurse Educator 
Referral Standard
1 0 100 0 1000 0 0 n/a n/a n/a n/a 100 0 0 0
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1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Satellite Clinics
ADA Standard
«
of
Charts
ADA recommendation 
tar Standard (A of 
occurrences per year)
Mode
Percentage
at
Mode
Perr^ntage at 
0
occurrences
Percentage at
1
occurrence
Percentage at
2
occurrences
Percentage at
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Pertaniage 
meeting or exceeding 
ADA reeommerrdalton
12 5Visitation Standard 16 4 0 37 5 37 5 25 0 6 3 18 8 6 3 6 3 87 5
Blood Pressure 
Measurement 
Standard
Weight
Measurement
Standard
16 4 0 688 688 6 3 6 3 125 0 0 6 3 93 6 6 3
16 4 0 688 688 188 0 0 6 3 0 0 6 3 93 8 6 3
Height
Measurement
Standard
4 4 0 750 750 250 0 0 0 0
0 0
0 0 0 0 100 0 0 0
Foot Examtnation 
Standard 16 4 0
938 93 6 6 3 0 0 0 0 0 0 1000 0 0
Hemoglobin A1C 
Detemrinatton 
Standard
16 4 0 750 750 125 6 3 6 3 0.0 0 0 1000 0 0
Lipid Profile 
Standard 12 1
0 667 867 8 3 n/a n/a n/a n/a 66 7 33 3
Microalbumin / 
Creatinine 
Ctearance 
Standard
13
13
1 0 76 9 76 9 154 n/e n/a n/a n/a 76 9 231
Dilated Eye Referral 
Standard
Dietitian Referral 
Standard
1 0 1000 100 0 0 0 n/a n/a n/a n/e 100 0 0 0
4 1 0 750 750 250 n/a n/a n/a n/a 75 0 250
Nurse Educator 
Referral Standard
15 1 0 87 5 87 5 12 5 n/a n/a n/a n/a 87 5 12 5
W
114
APPENDIX Q 
1995 Physician Compliance to ADA Standards for 
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1995 Physician Compiiance to ADA Standards for Patients with Type I Diabetes 
Satellite Clinics - Adults with Type I Diabetes
ADA Standard
n
of
Charts
ADA r*comm*r«jatton 
for Standard f# of 
occurrences per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrence*
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
ADA recommendation
Visitation Standard 11 A 1 an d) 27 3 18 2 27 3 0 0 27 3 0.0 27 3 72 7 27 3
Stood Pressure 
Measurement 
Standard
11 4 1 364 364 27 3 91 0 0 0 0 27 3 72 7 27 3
Weight
Measurement
Standard
11 4 0 545 545 27 3 0 0 0 0 18.2 0 0 8 1 8 18 2
Height
Measurement
Standard
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Foot Examination 
Standard
11 4 0 909 909 9 1 0 0 0 0 0 0 0 0 1000 0 0
Hemoglobin A1C 
Determination 
Standard
11 4 0 636 636 27 3 91 0 0 0 0 0 0 1000 0 0
Lipid Pnjfite 
Standard 11
1 0 6 36 636 27 3 n/a n/a n/a n/a 636 36 4
Micfoâlbiïmiri7~
Creatinine
Clearance
Starrdard
11 1 0 1000 1000 0 0 n/a n/a n/a n/a 1000 0 0
Dilated Eye Referral 
Standard 11
1 0 818 81 8 182 n/a n/a n/a n/a 818 18 2
Dietitian Referral 
Standard
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Nurse Educator 
Referral Standard 11
1 0 1000 1000 0 0 n/a n/a n/a n/a 1000 0 0
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1996 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Satellite Clinics - Adults with Type I Diabetes
ADA StamJafd
«
of
Charts
ADA recommendation 
lor Standard (A d  
oocunances per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
8 3
Percentage at 
3
occurrences 
16 7
Percentage at 
4
occurrences 
6 3
Percentage of 
occurrences 
>4
8 3
Percentage 
not meeting ADA 
recommendation
833
Percentage 
meeting «r exceeding 
ACA recommendation
Visitation Standard 12 4 0 41 7 41 7 16 7 167
Stood Pressure 
Measurement 
Standard
12 4 0 583 56 3 6 3 6 3 16 7 0 0  8 3 917 8 3
Weight
Measurement
Standard
12 4 0 66 7 667 16 7 0 0 6 3 0 0 8 3 917 8 3
Height
Measurement
Standard
n/a n/a n/a n/a n/e n/a n/a n/a n/a n/a n/a n/a
Foot Examination 
Standard 12 4 0 91 7 017 8 3 0 0 0 0 0 0 0 0 1000 0 0
Hemoglobin A1C 
Determination 
Standard
Liptd Profite 
Standard
12 4
1
1
0 750 75 0 6 3 8 3 8 3 0 0 0 0 1000 0 0
12 0 667 667 8 3 n/a n/a n/a n/a 667 333
Microalbumin / 
Creatinine 
Clearance 
_ ^ n d a r d __
dilated Eye Refisrral 
Standard
12 0 750 75 0 16 7 n/a n/a n/a n/a 7 5 0 2 50
12 1 0 1000 1000 0 0 n/a n/a n/a n/a 1000 0 0
Dietitian Referral 
Standard
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Nurse Educator 
Referral Standard 12
1 0 91.7 91 7 8 3 n/a n/a n/a n/a 917 8 3
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1995 Physician Compliance to ADA Standards for Patients with Type I Diabetes 
Satellite Clinics - Children with Type I Diabetes
ADA Standard 
Visitation Standard
tf
of
Charts
ADA recommendaton 
for Standard (# of 
occurrences per year)
Mode
Percentage
at
Mode
Percenlage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at
2
occurrences
Percentage at
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
> 4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
ADA recommendttwn
2504 4 0 500 500 25 0 0 0 0 0 250 OO 750
Blood Pressure 
Measurement 
Standard
4 4 0 100 0 1000 0 0 0 0 0 0 0 0 0 0 1000 0 0
Weight
Measurement
Standard
Height
Measurement
Standard
Fool Examination 
Standard
4
4
4
4 0 100 0 100 0 0 0 0 0 0 0 0 0 0 0 1000 0 0
4 0 100 0 100 0 0 0 0 0 0 0 0 0 DO 100 0 0 0
4 0 1000 100 0 0.0 0 0 0 0 0 0 DO 100 0 0 0
0 0
n/a
HemoglotJin A1C 
Determination 
Standard
Lipid Profile 
Standard
4
n/a
4 0 100 0 1000 0 0 0 0 0 0 0 0 0 0 1000
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Microalbumih /  
Creatinine 
Clearance 
Standard
1 1 0 1000 1000 0 0 n/a n/a n/a n/a 1000 0 0
0 0Dilated Eye Referral 
Standard
1 1 0 1000 1000 0 0 n/a n/a n/a n/a 1000
Dirtitian Referral 
Standard
Nurse Educator 
Referral Standard
4 1 0 1000 100 0 
1000
0 0
0 0
n/a
n/a
n/a n/a n/a 100 0 0 0
4 1 0 100 0 n/a n/a n/a 1000 0 0
VO
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1996 Physician Compiiance to ADA Standards for Patients with Type I Diabetes 
Sateilite Clinics - Children with Type I Diabetes
ADA Standard
Vwitation Standard
Blood Pressure 
Measurement 
Standard
Weigtit
Measurement
Standard
Height
Measurement
Standard
Foot Examination 
Standard
Hemogtotxn AlC 
Determination 
Standard
Lipid Profite 
Standard
n
of
Ctiarts
ADA rsccxnmsndation 
for Standard (d of 
oceufrenew per year)
Mode
Percentage
at
Mode
Percentage at 
0
occurrences
Percentage at 
1
occurrence
Percentage at 
2
occurrences
Percentage at 
3
occurrences
Percentage at 
4
occurrences
Percentage of 
occurrences 
>4
Percentage 
not meeting ADA 
recommendation
Percentage 
meeting or exceeding 
AC* recommendâtlon
4 4 1
0
0
500 260 500 DO 25 0 0 0 0 0 1000 0 0
4
4
4
4
1000
750
0 0  
75 0
0 0
250
0 0 0 0 0 0 0 0 100 0 0 0
0 0 0 0 0 0 0 0 1000 0 0
0 04 4 0 750  
100 0
75 0 
1000
2 5 0
0 0
0 0 0 0 0 0 0 0 1000
4
4
n/a
4
4
n/a
0 0 0 0 0 0 0 0 0 1000 0 0
0 750 75 0 25 0 0 0 0 0 0 0 0 0 1000 0 0
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Microaltiumin 1 
Creatinine 
Clearance 
___ ^ a n d a id ____
Dilated Eye Referral 
Standard
\
2
1
1
0 1000 100 0 0 0 n/a n/a n/a n/a 1000 0 0
0 100 0 1000 0 0 n/a n/a n/a n/a 1000 0 0
Dietitian Referral 
Standard
t\lurse Educator 
Refenal Standard
4 1
1
0
0
750
750
750  
75 0
2 50
2 50
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
750 25 0
4 750 2 50
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1995/1996 Mean Hemoglobin A1C Results 
All Sample Groups
1995/1996 Mean Hemoglobin A1C Results 
All Sample Groups
1995
Mean Hemoglobin A1C 
Values - All Physicians - 
Main Clinic
Mean Hemoglobin A1C 
Vailles of Adult (>18) Type i 
Diabetic Pabents - Main 
Clinic
Mean Hemoglobin A1C 
Values of Child (<18) Type 1 
Diabehc Pabents - Main
Clinic
Mean Hemoglobin Ate 
Values of Mate Pftysicians - 
Main Clinic
Mean Hemoglobin A1C 
Values of Female 
Physicians - Main Clinic
Mean Hemoglobin A1C 
Values of Physicians 
Treating >10 Type 1 Oiabebc 
Pabents ■ Main Clinic
Mean Hemoglobin AiC 
Values ot Physicians 
Treabng <10 Type 1 Diabetic 
Patients - Main Clinic
Mean Hemoglobin AIC 
Values • All Physicians - 
Satellite Clinics
Mean Hemoglobin AIC 
Values of Adult (>18) Type 1 
Diabetic Patients - Satellite 
Clinics
Mean Hemoglobin AIC 
Values of Child (<18) Type I 
Diabetic Patients - Satellite 
Clinics
Hemoglobin A1C Value (16) 8̂ 1 83 89 85 74 65 61 79 79 1
1996
Mean Hemoglobin A1C 
Values - All Physicians - 
Main Clinic
Mean Hemoglobin A1C 
VaHjes of Adult (>18) Type 1 
Diabetic Pabents - Main' 
Clinic
Mean Hemoglobin A1C 
Values of Child (<18) Type 1 
Diabetic Patents - Main 
Clinic
Mean Hemoglobin A1C 
Values of Mate Physicians • 
Main Clinic
Mean Hemoglobin A1C 
Values of Female 
Physicians ■ Main Clinic
Mean Hemoglobin A1C 
Values of Physicians 
Treating >10 Type 1 Diabebc 
Patients ■ Main Clinic
Mean Hemoglobin AIC 
Values ot Physicians 
Treating <10 Type 1 Oiatwbc 
Patients - Main Clinic
Mean Hemoglobin AIC 
Values • All Physicians • 
Satellite Clinics
Mean Hemoglobin AIC 
Values ol Adult (> 18) Type 1 
Diabebc Patients - Satellite
Clinics
Mean Hemoglobin AIC 
Values of ChiW (<18) Type 1 
Diabebc Patients ■ Satellite 
Clinics
Hemoglobin A1C Value (%) 87 86 9 7 88 81 67 86 9.7 98 95
K)U)
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1995/1996 Mean Age of Patiente with Type I D iabetes 125
Main Clinic and Satellite Clinics
Mean Age of Patients w/ 
Type 1 Diabetes • Main Clinic 
and SateWte Clinics
36.77
Mean Age of Pabents w/ 
Type 1 Diabetes - Main Clinic 36.74
Mean Age of Patients w/ 
Type 1 Diabetes - Satellite 
I Clinics
37.06
Mean Age of Children 
Patients w/ Type 1 C^abetes - 
Main Clinic and Satellite 
Clinics
12.86
Mean Age of Children 
Patients w/ Type 1 Diabetes - 
Main Clinic
13.11
Mean Age of CtiBdren 
Patients w/ Type 1 Diat>etes - 
Satellite Clinics
11.75
Mean Age of Adults Pabents 
w/ Type 1 Diat>ete$ - Main 
CKnIc and SatelRte CRnics
41.19
Mean Age of Adults Pabents 
w/ Type 1 Diabetes • Main 
Clinic
42.92
Mean Age of Adults Pabents 
w/ Type 1 Diabetes - Satellite 45.50 
Clinics
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1995/1996 Mean Age of O nset for Patients with Type I Diabetes 
Main Clinic and Satellite Clinics
Mean Age of Onset for 
Patients w/ Type I Diabetes - 
Main Clinic and Satellite 
Clinics
1 6 .4 8
Mean Age of Onset for 
Patients w/ Type 1 Diabetes - 
Main Clinic
1 6 .3 6
Mean Age of Onset for 
Patients w/ Type 1 Diat>etes - 
Satellite CRnics
1 7 .5 7
Mean Age of Onset for 
Children with Type 1 Diat>etes 
- Main Clhic and SateHite 
Clinics
6 .6 4
Mean Age of Onset for 
Children with Type 1 Diabetes 
- Main Clinic
7 .0 0
■
Mean Age of Onset for 
CtiRdren with Type 1 Diabetes 
- Satellite Clinics
5 .0 0
Mean Age of Onset for 
Adults with Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
1 8 .4 2
Mean Age of Onset for 
Adults with Type 1 Diat>etes - 
Main Clinic
..... .. ..... .
18 .0 1
1
Mean Age of Onset for j 
Adults with T ^ e  1 Diabetes ‘ 1  2 7 .1 0  
Satellite CRnics i
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L .  _ _ _ _ _ _  .  . .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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1995/1996 Mean Duration of Type I D iabetes for 
Patients with Type I Diabetes
129
Main Clinic and Satellite Clinics
Mean Duration of Type 1 
Diabetes • All Patients - Main 
Clinic and Satellite Clinics
19.99
Mean Duration of Type 1 
Diabetes - All Patients - Main 
Clinic
20.25
Mean Duration of Type 1 
Diabetes - All Patients - 
Satellite CRnics
17.79
Mean Duration of Type I 
Diabetes for Children - Main 
Clinic and Satellite CRnics
6.23
Mean Duration of Type 1 
Diabetes for Children - Main 
Clinic
6.11
Mean Duration of Type 1 
Diabetes for Children • 
Satellite Clinics
6.75
Mean Duration of Type 1 
Diabetes for Adults - Main 
Clinic and Satellite Clinics
22.70
Mean Duration of Type 1 
Diabetes for Adults - Main 
Clinic
22.75
Mean Duration of Type 1 
Diabetes for AdiAs - Satellite 
Clinics
22.20
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1995/1996 Number and Percent of Male and Female Patients
with Type I Diabetes 
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1995/1996 Number and Percent of Male and Female Patients with Type I Diabetes - Main Clinic/Satellite Clinics
Number of Male/Female 
Patients w/ Type I Diabetes - 
Main Clinic and Satellite 
Clinics
78 M/ 63 F
Number of Male/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic
67M/ 58F
Number of Male/Female 
Patients w/ Type 1 Diabetes - 
Satellite Clinics
11 M/5F 
16M/6F
Number of Male/Female 
Children with Type 1 Diabetes 
• Main Clinic and Satellite 
Clinics
Number of Male/Female 
Children with Type 1 Diabetes 
- Main Clinic
12M/6F
Numtier of Male/Female 
Children with Type 1 Diabetes 
- Satellite Clinics
4 M / 0 F
Number of Male/Female 
Adults with Type 1 Diat>etes • 
Main Clinic and Satellite 
Clinics
Number of Male/Female 
Adults with Type 1 Diabetes * 
Main Clinic
62 M/ 57 F 
55M/52F
Number of Male/Female 
Adults with Type 1 Diabetes - 
Satellite Clinics
7 M /5 F
Percentage of Mate/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
55.3% M/44.4% F
Percentage of Male/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic
53.6%M/45.4%F
Percentage of Mate/Female 
Patients w/ Type 1 Diabetes • 
Satellite Clinics
Percentage of Mate/Female 
Children with Type I Diatsetes 
- Main Clinic and Satellite 
Clinics
68.8%M/31.2%F
72.7%M/27.3%F
Percentage of Male/Female 
Children with Type 1 Diabetes 
- Main Clinic
Percentage of Male/Female 
Children with Type I Diabetes 
- Satellite Clinics
Percentage of Male/Female 
Adults with Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
66.7%M/33.3%F 
100%M/0%F 
52.1 %M/47.9%F
Percentage of Male/Female 
Adults with Type 1 Diabetes • 
Main Clinic
51.4% M/48.6 % F
Percentage of Male/Female 
Adults with Type 1 Diabetes - 
Satellite Clinics
68.3%M/41.7%F
U)
1995/1996 Number and Percent of Male and Female Patients with Type I Diabetes - Main Clinic/Satellite Clinics
Number of Male/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
78 M/ 63 F
Number of Male/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic
67 M/ 58 F
Number of Male/Female 
Patients w/ Type 1 Diabetes - 
Satellite Clinics
11 M/5F
Number of Male/Female 
Children with Type I Diataetes 
• Main Clinic and Satellite 
Clinics
16M/6F
Number of Male/Female 
Children with Type 1 Diabetes 
- Main Clinic
12M/6F
Numtier of Male/Female 
Children with Type 1 Diabetes 
- Satellite Clinics
4 M / 0 F
Number of Male/Female 
Adults with Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
62 M/ 57 F
Number of Male/Female 
Adults with Type 1 Diabetes - 
Main Clinic
55M/52F
Number of Male/Female 
Adults with Type ! Diabetes - 
Satellite Clinics
7 M/ 5 F
Percentage of Male/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
55.3% M / 44.4% F
Percentage of Male/Female 
Patients w/ Type 1 Diabetes - 
Main Clinic
53.6 %M745.4% F
Percentage of Male/Female 
Patients w/ Type 1 Diabetes - 
Satellite Clinics
68.8% M/31.2 % F
Percentage of Male/Female 
Children with Type I Diat>etes 
- Main Clinic and Satellite 
Clinics
72.7 %M 727.3% F
Percentage of Male/Female 
Children with Type 1 Diabetes 
- Main Clinic
66.7 %M 733,3% F
Percentage of Male/Female 
Children with Type t Diabetes 
- SateHite Clinics
100 %M 70% F
Percentage of Male/Female 
Adults with Type 1 Diabetes - 
Main Clinic and Satellite 
Clinics
52.1 %M 747.9% F
Percentage of Male/Female 
Adults with Type 1 Diabetes - 
Main Clinic
51.4%M748.6%F
Percentage of Male/Female 
Adults with Type 1 Diabetes - 
Satellite Clinics
58.3 %M 741.7% F
